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ABSTRACT 
 
Kinesin-12, Kif15 is a molecular motor involved in bipolar spindle assembly. 
Kif15 function is regulated through autoinhibition of its C-terminal tail and 
binding to the microtubule-associated protein Tpx2. Previous studies have 
reported Kif15 to function as a tetramer as well as a dimer. In this study, a 
cross-linking mass spectrometry (XL-MS) protocol and analysis workflow was 
developed to study the structural organisation of Kif15. Using XL-MS studies, 
it was found that Kif15 adopts a parallel tetramer conformation, which is 
autoinhibited by its C-terminal leucine zipper. Next, we show that this 
autoinhibited conformation is stabilised by the binding partner Tpx2. We also 
show that there is a shift in the binding interface between Kif15 and Tpx2 when 
microtubules are present and absent. In the presence of microtubules, Tpx2 
mainly binds to the leucine-zipper of the Kif15 motor, whereas in the absence 
of the microtubules, this binding is exclusively localised to the fourth coiled-
coil. We also reveal that Tpx2 adopts a dimeric conformation at physiological 
ionic strength. Finally, to understand the function of Kif15 in-vivo, we have 
developed putative Kif15 knock-out cell lines and developed a cross-linking 
protocol to cross-link Kif15 in cells.  
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Chapter 1: Introduction 
 
 
1.1 Cytoskeleton 
 
The cytoskeleton is a dynamic cellular structure that mediates many biological 
phenomena, such as cell division, cell migration and extracellular matrix 
organisation. Specifically, the cytoskeleton is required to promote force 
generation to facilitate cell movement and maintain the structural integrity of 
intracellular compartments (Fletcher and Mullins, 2010).  
 
To carry out these cellular functions, the cytoskeleton is composed of three 
elements; actin, intermediate filaments and microtubules. All components of 
the cytoskeleton can directly or indirectly interact with each other to mediate 
different cellular processes. Actin was initially discovered to be involved in 
promoting skeletal muscle contraction (Szent-Györgyi,1943). Actin monomers 
(G-actin) can polymerise to form the actin microfilament (F-actin). Both the 
polymerised and monomeric form of actin are present in cells and the 
assembly or disassembly of actin is regulated in response to biochemical 
stimuli (Ridley and Hall, 1992). Actin is mainly localised to the cell periphery 
and is predominantly involved in promoting cell movement (Carlier and 
Pantaloni, 2007). The polymerised actin filaments can also function as a rail 
for the motility of the molecular motors from the Myosin family (Sellers, 2000). 
The interaction between actin and the microtubule cytoskeletons is mediated 
through bi-functional proteins such as Tau and the microtubule-associated 
protein 2 (MAP2) which contain binding sites for both filament systems (Griffith 
and Pollard, 1982). Intermediate filaments are the most flexible cytoskeletal 
component as they have higher tensile strength than the other cytoskeletal 
elements (Herrmann et al., 2007). Also, they can interact with microtubules 
and the actin cytoskeleton through binding to a class of proteins called plectins 
(Wiche, 1998). A common class of intermediate filaments are nuclear lamins, 
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which are involved in many processes such as nuclear-envelope breakdown, 
which occurs after the nuclear lamins are phosphorylated by cyclin-dependent  
kinases (Tsai et al., 2006) and providing mechanical stability to the nucleus. 
(Dechat et al., 2008). Intermediate filaments have also been found to play a 
role in cellular mechanotransduction: Shear stress forces has been shown to 
mediate a conformational change in vimentin and keratin filaments which can, 
for example, increase the stiffness of the keratin fibres at the cell edges 
(Sivaramakrishnan et al., 2008, Helmke et al., 2000).    
 
Microtubules are filament-like “tracks” that mediate various processes, such 
as intracellular transport, cell division and motility in eukaryotic cells through 
assembly into large-scale microtubule-based structures, such as cilia, flagella 
and the mitotic spindle. Microtubules are formed through the polymerisation of 
the heterodimeric a and b tubulin subunits (figure 1.1). In the presence of GTP, 
13 tubulin polymers are assembled together in a parallel organisation to form 
the polarised microtubule with a hollow core and is 25 nm in diameter (Evans 
et al., 1985). The tubulin polymers are dynamic structures which can undergo 
rapid polymerisation and depolymerisation. This is mediated through the 
hydrolysis of GTP, which bind to the tubulin subunits. Tubulin subunits exist in 
a GTP or a GDP state. When the GTP-bound tubulin subunits are incorporated 
into the microtubules, they become hydrolysed into GDP. The growing 
microtubule end (plus end) has a cap of GTP-tubulin, which promotes the 
stability of the microtubule and protects it from disassembly. When the 
hydrolysis of GTP-bound tubulin reaches the growing microtubule tip, this 
promotes catastrophe and switches to rapid microtubule shrinkage. The 
shrinkage can be rescued by the binding of GTP-bound tubulin, which allows 
microtubule growth and restores the cap of GTP-tubulin. The stochastic 
switching between the states growth and shrinkage is known as dynamic 
instability (Mitchison and Kirschner, 1984) . 
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Figure 1. 1: Microtubule structure.  
Depicted in this diagram is the microtubule, made up of 13 protofilaments 
with a hollow core and 25 nm in diameter. In dark grey is the a-tubulin 
subunit and light grey is the b-tubulin subunit, which forms a tubulin 
heterodimer that are added onto the growing microtubule plus end.  
 
 
Kinesin and Dynein motors use microtubules as tracks for directional transport 
(Hirokawa, 1998). These motors utilise ATP hydrolysis into ADP and Pi to 
move along the microtubule tracks and transport cargo within the cells. The 
movement of these motors generates directional forces which drive complex 
biological processes such as bipolar spindle assembly during cell division. The 
motors bind to the microtubule lattice through a distinct microtubule binding 
site in the motor domain, with many containing a non-ATP dependent binding 
site in the tail to enhance their binding to the microtubules. Microtubule 
associated proteins (MAPs) are another class of proteins which bind and 
regulate microtubules and motor function (Etienne-Manneville, 2010). MAPs 
can be split into three classes; MT plus-end tracking proteins, MT minus-end 
tracking proteins and MAPs that decorate the microtubule lattice (Schuyler and 
Pellman, 2001, Akhmanova and Steinmetz, 2008, Hendershott and Vale, 
2014, Jiang et al., 2014) . They are non-motor proteins which can affect the 
ability of the MTs to grow, shrink, bundle and the microtubule dynamics 
required for processes such as spindle assembly and stability. They are also 
required to localise several motors to the microtubules of the mitotic spindle 
(Wittmann et al., 1998, Chu et al., 2016). 
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1.2 Molecular Motors 
 
1.2.1 Kinesin Motor Protein Family 
 
Kinesins are a subgroup of molecular motors that bind microtubules and can 
be grouped into 14 family members based on their sequence conservation 
(Lawrence et al., 2004, Miki et al., 2005). Most kinesins contain three domains; 
a motor domain, a coiled-coil domain and a carboxy (C)-terminal tail most 
commonly used for cargo binding. The motor domain is where the ATP and 
microtubule binding sites are localised, whereas the neck linker connects the 
motor domain to the coiled-coiled stalk. Kinesins 1-12 are n-kinesins, whereby 
their motor domain is N-terminal. The Kinesin-14 family are c-kinesins and 
have a C-terminal ATPase motor domain, whereas the Kinesin-13s are m-
kinesins, which have their motor domain in the middle region of the protein, 
with two coiled-coil tails at both the C- and N-terminal ends. As such, n-
kinesins are generally plus-end directed, whereas c-kinesins are minus-end 
directed. Some motors, such as the yeast kinesin-5s, Cin8 and Cut7 can 
operate in a bidirectional mode (Roostalu et al., 2011, Edamatsu, 2014). M-
kinesin group has an interesting microtubule depolymerisation activity that has 
significant implications for multiple biological processes (Ems-McClung and 
Walczak, 2010, Armond et al., 2015). 
 
The conventional Kinesin, Kinesin-1 or the Kinesin heavy chain (KHC), is the 
most studied kinesin and work on this motor has helped to elucidate the 
ATPase cycle adopted by kinesins to drive their motility along microtubules 
(Hackney, 1994, Block et al., 1990, Cross, 2004, Carter and Cross, 2006, 
Carter and Cross, 2005). Each processive kinesin step on the microtubules 
(8-nm) hydrolyses one ATP molecule (Schnitzer and Block, 1997). As both 
motor heads are required to processively move along the microtubule lattice, 
the ATP hydrolysis must be coordinated to enable the motor to move using a 
hand over hand mechanism, whereby each head switches between a leading 
and trailing state (Howard et al., 1989, Block et al., 1990, Gennerich and Vale, 
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2009, Mori et al., 2007, Asbury et al., 2003, Cross, 1995). To do this, Kinesin 
motor domains have an ADP molecule bound in its active site, until the kinesin 
attaches to the microtubule. This attachment causes ATP to bind to the active 
site of the attached head. ATP binding then induces the neck-linker to undergo 
a conformational switch which moves the lagging motor head forward and 
allows it to come into close contact with next available binding site on the 
microtubule. The attached trailing head hydrolyses ATP to ADP and Pi and 
this allows the leading head to bind the microtubule. The trailing head releases 
the phosphate group and now in its ADP bound state, dissociates from the 
microtubules.  
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Figure 1. 2: Kinesin family tree.  
Kinesins were grouped based on sequence alignment from 611 kinesin family 
proteins. The “KIF” nomenclature is exclusive for mammalian Kinesins. The 
kinesins were grouped into a total of 14 families. The taxonomy code used for 
the proteins are as follows; v, red = vertebrate; I, pink= insect; n, purple= 
nematode; p, green=higher plant; f, blue=fungi. Figure from Miki et al., 2005. 
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Kinesin superfamily is involved in mediating many cellular processes such as 
intracellular trafficking and ciliary functions. Henceforth, the focus here will be 
on the role of Kinesins in cell division. RNA-interference (RNAi) experiments 
in Drosophila flies has shown the crucial role kinesins play in several stages 
of mitosis, such as bipolar spindle assembly and chromosome segregation 
(Goshima and Vale, 2003). It has also been shown that specific Kinesin family 
members are required to carry out functions for distinct stages of cell division. 
In total, 9 mammalian Kinesin family members have been found to play a 
crucial role in the different stages of mitosis (Yen et al., 1991, Blangy et al., 
1995, Mountain et al., 1999, Ganem and Compton, 2004, Zhu and Jiang, 
2005, Zhu et al., 2005, Carleton et al., 2006, Tanenbaum et al., 2009). 
 
The classic mitotic kinesin is Eg5. This Kinesin-5 (also called Kif11), was 
amongst the first mitotic kinesins to be characterised. RNAi experiments 
against Eg5 results in the formation of a monopolar spindle (Sawin et al., 
1992). Eg5 is a 120 kDa plus-end directed, bipolar tetramer stabilised by a 
four-helix bundle (BASS domain), with two sets of motor domains at either end 
of the protein (Acar et al., 2013, Scholey et al., 2014). The C-terminal end of 
Eg5 contains an additional microtubule binding site, which given its anti-
parallel conformation, is situated next to a pair of motor domain at either end 
of the molecule and helps the kinesin cross-link and slide overlapping, anti-
parallel microtubules (Tao et al., 2006, Weinger et al., 2011). In prophase, Eg5 
localises to the overlapping, antiparallel microtubule bundles situated between 
the centrosomes. Eg5 then moves these microtubules apart as the motor 
domain step towards the plus end of microtubules, thus initiating centrosome 
separation. After nuclear envelope breakdown, Eg5 is still involved in 
centrosome separation, however, once the bipolar spindle has been 
established, Eg5 is no longer essential as another motor, Kinesin-12 Kif15 is 
able to compensate for Eg5 to maintain the bipolar spindle (Vanneste et al., 
2009, Tanenbaum et al., 2009) (see 4.1.2 Kif15 in Bipolar Spindle Assembly).  
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Kinesins also play a crucial role in chromosome congression to the spindle 
equator. This includes the Kinesin-4 and Kinesin-10 family, which are known 
as chromokinesins, as they have a DNA binding site, which enables them to 
localise to the chromosomes (Funabiki and Murray, 2000). The removal of 
these chromokinesins results in chromosome misalignment. Another class of 
kinesins involved in chromosome congression is the Kinesin-13. This kinesin 
was first discovered as a protein concentrated in the inner centromere 
(Wordeman and Mitchison, 1995). Kinesin-13’s are unusual as they have their 
motor head in the middle of the protein sequence and can function as a 
depolymerase at both microtubule ends (Hendershott and Vale, 2014, 
Goodwin and Vale, 2010, Wang et al., 2017, Benoit et al., 2018). These 
depolymerising kinesins regulate microtubule dynamics at the kinetochore, 
which is important in mediating chromosome capture, congression and 
alignment (Maney et al., 1998, Kline-Smith et al., 2004, Armond et al., 2015). 
The kinesin-8 family is also another member of the depolymerising kinesins 
group which modulate the assembly/disassembly dynamics of the 
microtubules. They are highly processive motors that are able to tip-track the 
microtubule plus-ends and depolymerise the microtubules in a length-
dependent way (Varga et al., 2006, Mayr et al., 2007). The removal of Kinesin-
8 from cells results in a lengthening of the microtubules and the spindle 
(Wordeman, 2010). Another Kinesin family protein involved in chromosome 
congression and alignment is Kinesin-7 (CENP-E). This kinesin can bind 
directly to the outer kinetochores as well as the microtubules. Kinesin-7 RNAi 
results in chromosome misalignment and incorrect segregation (Wood et al., 
1997, Schaar et al., 1997).  
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1.2.2 Structural organisation of Kinesins 
 
As previously described, Kinesin organisation can be divided into two main 
domains; a globular N-terminal ATPase motor domain, approximately 300 
amino acids long, and a a-helical coiled coil, with unstructured regions 
distributed between the coils (Hirokawa et al., 1989, Yang et al., 1989). The 
motor domain is followed by a short neck-linker region, which connects the 
motor domain to the C-terminal coiled-coil. Based on structural data obtained 
for many Kinesins, it is clear that the motor domain is highly conserved 
amongst this class of motors, with the Myosin motor group also showing high 
similarity in their catalytic core (Kull et al., 1996, Sablin et al., 1996, Kull et al., 
1998). The central region of the motor domain consists of b-sheets, with a-
helices surrounding on both sides. The microtubule binding site and the ATP 
hydrolysis site are both located on the b-sheets, however they are on opposite 
end (Kull et al., 1996).  
 
The highly conserved ATP hydrolysis site is not only found in the Kinesin and 
Myosin motor families, but also in the Ras G-protein family (Kull et al., 1998). 
This is due to these proteins all containing a phosphate-binding loop (p-loop) 
in the motor domain, and the binding of an ATP molecule to the active core 
causes the two adjacent regions Switch-1 (loop-9) and Switch-2 (a-helix4, 
loop-12 and a-helix-5)  to close up and assume an active conformation, which 
is stabilised by a salt bridge forming between the Switch-1 and Switch-2 
regions (Kikkawa et al., 2001). This closed conformation and the presence of 
a Mg+ ion in the active site induces ATP to be hydrolysed into ADP and Pi. The 
release of the phosphate group causes the motor domain to change its 
configuration back to the open conformation (Kikkawa et al., 2001).  The neck-
linker is a region of 12-18 amino acids, which is important in connecting the 
motor domain to the extended coiled-coil tail. It has also been found to be 
important in mediating hand-over-hand mechanism required for the 
processive motility of the kinesin motors (Rice et al., 1999). This is because 
the ATP binding to the leading head induces a structural conformation in the 
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neck-linker region, which allows the trailing head to shift forward 16 nm and 
bind to the next microtubule binding site. Of the current structures available 
for Kinesins, they tend to be monomeric kinesins, as the dimeric kinesins are 
difficult to crystallise. However, a recent study has provided insight into the 
motility mechanism of a microtubule-bound dimeric kinesin using an ATP 
analog (Liu et al., 2017). In monomeric kinesins, it has been shown that the 
docking of the neck region is associated with structural rearrangement of three 
Kinesin domains, which includes the P-loop subdomain (Cao et al., 2014, 
Shang et al., 2014). Whilst there is less substantial rotation than the P-loop, 
the switch I/II subdomains of the Kinesin head also undergo movement, which 
is proposed to hinder the conformational change in the neck linker and 
prevents docking in the leading head domain (Shang et al., 2014). Similar 
findings were identified for the dimeric kinesins, however, the rotations  of 
these subdomains is smaller for the dimeric kinesin and the movements only 
occur in the leading head and not the trailing head (Liu et al., 2017). 
Interestingly, the neck region has also been revealed to be essential in 
determining the directional movement of the motor (Case et al., 1997, 
Henningsen and Schliwa, 1997). Also, the length of the kinesin neck-linker has 
been shown to undergo structural changes which is thought to affect the 
motility of these motors. For example, it has been suggested that the 
probability of a motor to undergo diffusion on the microtubule lattice, is 
dependent on the length of the neck-linker region; the longer the neck-linker 
region, the higher the probability of diffusion, which reduces microtubule 
stepping and leads to subsequent release of the motor heads from the 
microtubules (Andreasson et al., 2015). Studies of the neck-linker region has 
shown that there is a high sequence variation for the length of the neck-linker 
between the different Kinesin family members, although there is high 
sequence conservation within the same family subgroup (Hariharan and 
Hancock, 2009).  
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The Kinesin coiled-coil tails is variable in length, with the Kinesin-7 containing 
the longest known tail at 230 nm (Kim et al., 2008). The tail region of Kinesins 
displays the highest divergence amongst the Kinesin family as they contain 
binding sites for various binding partners and substrates, which allows the 
motors to mediate specific functions. The Kinesin tail is also important in 
folding back onto the motor domain to auto-inhibit the motor. Studies, including 
NMR and Bioinformatics analysis of all human 43 kinesins has also confirmed 
that the Kinesin tail is highly intrinsically unstructured, suggesting it can adopt 
several conformations, instead of a singular native configuration (Seeger et 
al., 2012). Cryo-EM and crystallography studies are optimal for studying static 
structures, and due to the inherent flexibility of Kinesins, these techniques may 
always not be the best method of choice. However, Cryo-EM has been used 
to make significant development has been made in understanding the 
structural basis of Kinesin assembly and function (Moores et al., 2002, Endres 
et al., 2006, Sindelar and Downing, 2007). 
 
 
1.2.3 Regulation of Kinesins 
 
Kinesins are important in mediating many cellular functions. As such, it is very 
important to fully understand the different mechanisms by which Kinesin 
activity can be regulated. It is crucial that Kinesins do not overcrowd the 
microtubules or unnecessarily undergo ATP hydrolysis, thus their activity 
needs to be modulated.  
 
A common mechanism to regulate Kinesin activity is through auto-inhibition. 
This mechanism has best been characterised for the Kinesin-1 family, 
however it has been identified as a regulatory mechanism in several other 
kinesins as well (Hackney et al., 1992, Verhey et al., 1998, Coy et al., 1999).  
A crystal structure of a dimeric kinesin motor domain with its tail has provided 
great insight into the structural basis of the autoinhibition mechanisms of 
kinesins (Kaan et al., 2011). The autoinhibited conformation ensures that the 
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C-terminal tail of the kinesin forms direct cross-links at two distinct sites, the 
neck coil and the tail (Kaan et al., 2011). Unexpectedly, it has also been shown 
that for a dimeric kinesin, only one of the tails folds back and makes direct 
contact with the motor domain (Hackney et al., 2009). This autoinhibited 
conformation requires the kinesin to contain a hinge region in the coiled-coil 
tail to allow the tail to fold back on itself. This has been confirmed in several 
autoinhibited kinesins, as the removal of these hinge regions abrogates the 
ability of the kinesin to fold back on itself, thus they remain in a constitutively 
active conformation (Coy et al., 1999). Also, this folded conformation means 
that the close proximity of the tail to the motor domain, blocks the microtubule 
binding and the ATPase activity of the Kinesin, thus it remains in an inactive 
state.  For Kinesin-1, a highly conserved region in the tail (the IAK domain) is 
essential for  Kinesin-1 autoinhibition (Hackney et al., 2009). The presence of 
an adjacent highly charged region, further enhances the autoinhibition.   
Kinesin-1 autoinhibition is also achieved by the binding of the Kinesin Heavy 
Chain (KHC) in-between the Kinesin-1 motor heads, which prevents the 
processive movement of the motor (Cai et al., 2007). CENP-E, a Kinesin-7 
protein is another mitotic kinesin regulated by autoinhibition. As mentioned, 
this protein plays a crucial role in chromosome congression. The kinesin 
normally adopts a folded conformation, whereby its motor domain is 
inaccessible to the microtubules. To activate the Kinesin, C-terminal 
phosphorylation by MPS1 or CDK-1 releases the autoinhibited conformation 
and activates the kinesin to facilitate its function for correct chromosome 
congression (Espeut et al., 2008). The kinesin Eg5 can also auto-regulate its 
activity through a slightly different mechanism. The motor uses energy-
independent diffusion along a single microtubule track, but adopts processive 
movement when it comes into contact with a second microtubule (Kapitein et 
al., 2008). This ensures Eg5 only utilises ATP to undergo directed movement 
when it cross-links two microtubules. Lysine acetylation of residue 146 in the 
motor domain of Eg5 can also activate the motor (Muretta et al., 2018). 
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Kinesins can also be regulated through temporal and spatial protein 
expression. Mitotic kinesins are required for distinct function during Mitosis 
therefore they are only required to be expressed at certain stages of cell 
division. For example, there are transcription factors, such as FOXM1 that 
selectively activates kinesin proteins at the start of Mitosis (Alvarez-Fernandez 
and Medema, 2013). As well as the regulating their synthesis, other protein 
complexes, such as the ubiquitin ligase APC/C complex is required to degrade 
Kinesins containing a targeted KEN motif in their destruction domain (D-box). 
The kinesin-10, Kid, is a well described kinesin regulated by APC/C complex 
degradation. As previously described, this kinesin is an important plus-end 
directed motor required for chromosome congression. However, during the 
onset of anaphase, this kinesin is targeted for degradation, to abolish the polar 
ejection force which mediates chromosome congression, thus promoting the 
chromosomes to be pulled to opposite spindle poles (Vanneste et al., 2011, 
Funabiki and Murray, 2000).  
 
Another important regulatory mechanism for Kinesins is protein-protein 
interactions. EB proteins have been found to act as a scaffold for the 
localisation of Kinesins to the microtubule plus-end. EB proteins are well 
characterised +TIP tracking proteins and Kinesins such as Kinesin-8 and 
Kinesin-13 are known to contain an SxIP motif to interact with the EB proteins 
and localise to the microtubule plus end (Akhmanova and Steinmetz, 2008, 
Honnappa et al., 2009, Stout et al., 2011). For example, it was shown that 
Kif18b localisation to the astral microtubules plus-ends requires EB1 and 
Kif18b can also form a complex with MCAK to enhance each other’s affinity 
for the microtubule plus-end (Tanenbaum et al., 2011). Kinesin-5 and Kinesin-
12 have been shown to bind and track microtubule plus-end independently of 
EB proteins. Proteins, such as the MAP Tpx2 can bind Kinesins and regulate 
their localisation. Kinesin-5 binding to Tpx2 is required to localise the motor to 
the spindle and inhibits the motility of the motor in-vitro (Ma et al., 2011, 
Balchand et al., 2015). Tpx2 was discovered as a spindle targeting protein for 
Xklp2, the Xenopus homologue of Kinesin-12 Kif15 (Wittmann et al., 
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1998).Tpx2 is important in acentrosomal-independent microtubule nucleation 
(Chen et al., 2017) and is able to promote microtubule nucleation in-vitro using 
purified tubulin (Roostalu et al., 2015). Tpx2 also plays a crucial role 
throughout the different stages of Mitosis, through the recruitment of proteins 
to the bipolar spindle or direct activation of mitotic regulators. Amongst these 
regulators is the serine/threonine mitotic kinase Aurora A. Residues 1-43 of 
Tpx2 is required for binding to Aurora A, which stabilises the 
autophosphorylation of Thr288 in the kinase loop through a conformational 
shift which makes the Thr288 residue inaccessible for dephosphorylation by 
protein phosphatase 1 (PP1) (Bayliss et al., 2003). Tpx2 is also required for 
the localisation of the kinase to the mitotic spindle (Kufer et al., 2002). 
 
Phosphorylation by mitotic kinases is an essential mechanism utilised to 
regulate mitotic kinesin localisation during mitosis. Eg5 has been shown to  
localise to the spindle microtubules through the phosphorylation of its C-
terminal tail by CDK1 (Sawin and Mitchison, 1995, Blangy et al., 1995). 
Another example is the multi-phosphorylation of the Kinesin-13, MCAK by 
Aurora A, which regulates its localisation to the kinetochores, spindle poles 
and chromosome arms (reviewed in (Ems-McClung and Walczak, 2010). The 
activities of the kinase CDK1 and protein phosphatase 1 (PP1) are required 
for  Kif18A-dependent regulation of pre-anaphase chromosome oscillations 
(Hafner et al., 2014).  
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1.3 Kinesin-12  
 
1.3.1 Kinesin-12 Kif15 
 
The naming of the Kinesin families, including the Kinesin-12 family, was 
initially based on sequence conservation and function (Hirokawa, 1998). 
However, based on substantial genome sequencing since the original paper, 
there has been a suggestion that some of the Kinesin families were incorrectly 
grouped. Amongst these is the Kinesin-12 family, which was suggested to be 
split into Kinesin-16 (containing HsKif12) and Kinesin-15 (HsKif15 and 
AtPAKRP1) (Wickstead and Gull, 2006). The Kinesin-12 family has been 
shown to be involved in bipolar spindle assembly in both animal and plant 
cells. PAKRP1/Kinesin-12A and PAKRP1L/Kinesin-12B were identified as 
playing a critical role in cytokinesis of male gametogenesis in Arabidopsis  
(Lee et al., 2007). 
 
The kinesin-12 Kif15, was first discovered in Xenopus laevis (Xklp2), where it 
was shown to be  localised to the centrosomes instead of the chromosomes 
and is required for maintenance of the bipolar spindle (Boleti et al., 1996). 
Xklp2 was initially characterised as a homodimeric Kinesin, which requires the 
microtubule-associated protein Tpx2 (targeting protein for Xklp2) to localise to 
the mitotic spindle and microtubule minus-ends (Wittmann et al., 1998). Also, 
a single point mutation in the C-terminal leucine zipper of Xklp2 was shown to 
abrogate spindle targeting of the motor. The Caenorhabditis elegans ( C. 
elegans) and sea urchin homologues for Xklp2 have also shown that this 
Kinesin plays a role in bipolar spindle assembly (Rogers et al., 2000, Segbert 
et al., 2003). The human Kif15 (Hklp2) is a kinesin which mainly functions in 
mitosis and has some overlapping functions with Eg5, however it is structurally 
and mechanistically different from Eg5 (Vanneste et al., 2009). The small 
molecule inhibitor of Eg5 (Monastrol) is known to recognise and bind to Loop-
5 of Eg5, which stabilises the inactive conformation of the motor and puts it in 
a weakly bound state (Cochran et al., 2005, Crevel et al., 2004). The structure 
of the L5 region is specific for Eg5, thus explaining why this inhibitor is 
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ineffective for Kif15. Human Kif15 has been reported as a homotetramer 
based on biochemical examination of the full length Kif15 expressed and 
purified from insect cells (Drechsler et al., 2014, Drechsler and McAinsh, 2016) 
and from Kif15 protein purified from mammalian cell extracts (Mann et al., 
2017). However, the Ohi lab report Kif15 to function as a dimer and propose 
based on truncation experiments that Kif15 has an additional microtubule 
binding site in the region containing the first coiled-coil domain and the 
adjacent unstructured region (Kif15 1-700) (Sturgill et al., 2014).  
 
The N-terminal motor domain of Kif15 is the main microtubule binding site 
(Figure 1.4B, 1.4C). A crystal structure for Kif15 motor domain (residues 19-
375), show the motor adopts the conserved kinesin fold (Klejnot et al., 2014).  
Single molecule assays have shown that Kif15 is a plus-end directed motor 
with short minus-end directed movement on microtubules and that it is able to 
processively walk for over 1 µm and undergo diffusion on the microtubule 
lattice (Drechser et al., 2014). However, the run-length of Kif15 motors is 
significantly lower under load, with a stall force of ~6 pN (McHugh et al., 2018). 
The motor is also able to effectively switch microtubule tracks and is able to 
recognise and bind to the plus-ends, independently of EB proteins (Drechsler 
et al., 2014, Kapitein et al., 2005). Kif15 is also able to cross-link microtubules 
however, no clear evidence to indicate extensile sliding of anti-parallel 
microtubules was identified. In fact, fully anti-parallel microtubules tend to 
recruit multiple motors with no movement of microtubules observed.  It was 
also shown that in the presence of Tpx2, Kif15 binding to microtubules was 
enhanced. Tpx2 significantly reduces the proportion of motile motors and 
optical trapping experiments further confirmed this, but also showed that Tpx2 
increased the load-bearing capability of Kif15 (Drechsler et al., 2014, Mann et 
al., 2017). Kif15 motility can also be regulated by autoinhibition, mediated by 
the C-terminal tail (residues 701-1388) (Sturgill et al., 2014). Specifically, the 
C-terminal leucine-zipper (residues 1294-1388) has been identified as 
essential in stabilising this autoinhibited conformation that tightly locks onto 
the microtubules, which is further stabilised by the presence of Tpx2 (McHugh 
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et al., 2017).On dynamic microtubules, the motor has also been shown to track 
microtubule plus-ends, cross-link and transport one microtubule relative to the 
other, resulting in the formation of parallel microtubule bundles (Drechsler and 
McAinsh, 2016, Drechsler et al., 2014).  The role of Kif15 in driving parallel 
bundles is also consistent with studies with C. elegans Kinesin-12 (KLP-18), 
showing this motor is required for promoting the formation of parallel 
microtubules around meiotic chromosomes (Segbert et al., 2003). It has also 
been suggested that a second microtubule binding site is required for Kif15-
dependent microtubule sliding (Sturgill et al., 2014). 
 
In recent years, several studies have attempted to characterize the 
mechanochemical properties of Kif15 (Drechsler et al., 2014, Reinemann et 
al., 2017, McHugh et al., 2018, Milic et al., 2018). It has been reported that the 
Kif15 motor is processive under assisting and hindering loads, and the run-
length of Kif15 motors significantly lower under load, with a stall force of ~6 
pN (McHugh et al., 2018, Milic et al., 2018). Further work has also been done 
to characterize the mechanochemical cycle of Kif15, which can be simplified 
into 4 steps as seen in figure 1.3 (Milic et al., 2018). The first step involves the 
binding of ATP to the nucleotide-free, microtubule-bound (apo) leading head 
in the ATP-waiting state. This step is followed by the partial docking of the 
neck-linker (NL) to the leading head. Full docking of the NL occurs after ATP 
hydrolysis which enables the tethered head to bind to the microtubules on the 
next available binding site and release ADP. The final step is the release of 
the phosphate group, which detaches the trailing head from the microtubule 
and converts the kinesin to its original one-head-bound state. Modelling the 
mechanochemical cycle between Kif15 and Eg5 has produced interesting 
results; the rates of transitions for the Kif15 steps were up to 4-fold faster than 
those rates reported for Eg5. For Kif15, the phosphate-release step which 
promotes the release of the rear-head, is 10 times faster than the hydrolysis 
step. This indicates that unlike Eg5, Kif15 spends most of its time in a single-
head-bound state (Milic et al., 2018, McHugh et al., 2018). 
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Figure 1.3: Mechanochemical cycle of Kif15.  
This cycle can be simplified into 4 steps. Firstly, ATP molecule binds to the 
microtubule-bound, nucleotide-free (Æ) leading head. This is followed by a 
mechanical step, which involves the partial docking of the neck-linker to the 
microtubule-bound head. ATP hydrolysis then promotes the complete docking 
of the NL and ADP release from the tethered head promotes binding to the 
microtubules. Finally, the release of the phosphate group detaches the trailing 
head and returns the motor to its single-head-bound state.  
 
The N-terminal motor domain of Kif15 is also the proposed binding site for the 
novel binding partner KBP (Brouwers et al., 2017, Kevenaar et al., 2016). It 
was shown that KBP does not have a significant effect on Kif15 localisation to 
the spindle poles, but KBP depletion reduces Kif15 localisation to the spindle 
equator and the chromosomes (Brouwers et al., 2017). Kif15’s localisation to 
the chromosomes is mainly mediated by the chromosome marker Ki67. 
Depletion of Ki67 results in significance decrease of Kif15 levels from the 
chromosomes but localisation to the spindle is retained (Vanneste et al., 
2011).  
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In interphase, Kif15 forms evenly dispersed puncta in the cytoplasm and co-
localise with the microtubules, however Tpx2 is required to localise the motor 
to the spindle microtubules and k-fibres in prometaphase. Kif15 can also co-
localise to the outer-kinetochore protein Hec1 in HeLa cells (Sturgill and Ohi, 
2013). The C-terminal region (residues 710-747) of Tpx2 has been confirmed 
as essential in localising Kif15 to the mitotic spindle (Mann et al., 2017). It has 
also been recently shown that phosphorylation of Kif15 by Aurora A at S1169 
is important in localising the motor the spindle poles, as it has been shown 
that spindle localisation of Kif15 is decreased upon Aurora A inhibition (van 
Heesbeen et al., 2017). Both Aurora A and Kif15 activity is regulated by Tpx2 
so it is possible that the phosphorylation by Aurora A promotes Kif15 to fold 
into a conformation that makes the leucine-zipper accessible for Tpx2 binding.  
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Figure 1. 4: Domain organisation of Kif15.  
A; Coiled-coils prediction plot from Uniprot. B; Domain organisation of Kif15 
based on ELM (Eukaryotic Linear Motif) coiled coil prediction software. A 
minimum of 20 amino acids (or about 3 heptad repeats) were used for the 
coiled-coil predictions. N-terminal motor domain is where the kinesin binding 
protein (KBP) has been shown to bind. The first coiled coil domain harbours a 
proposed second ATP-independent microtubule binding site. The C-terminal 
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tail contains the Ki67 and Tpx2 binding sites. The phosphorylation sites are 
localised to unstructured region adjacent to the motor domain and the fourth 
coiled-coil (CC4) domain. C; Crystal structure of Kif15 motor domain (from 
Klejnot et al., 2014).  
 
 
 
1.3.2 Kif15 in Bipolar Spindle Assembly 
 
The mitotic spindle has a bipolar configuration with approximate dimensions 
of 10 x 10 x 10 µm, and is composed of a microtubule super structure and 
additional protein components. At the spindle poles the microtubules are 
anchored at the microtubule organizing centre (MTOC), which is the 
centrosome for eukaroytic cells. The bipolar spindle contains three 
microtubule elements; astral microtubules, inter-polar microtubules and 
kinetochore fibres (figure 1.4). The astral microtubules are microtubules 
emanating from the centrosomes to the cell cortex, thus help spindle 
positioning and control the cell division plane orientation (Grill et al., 2001, Grill 
et al., 2003).  Despite their role in centrosome separation during prophase 
(Rosenblatt, 2005), astral microtubules are not essential for cell division 
(Khodjakov et al., 2000). 
 
The interpolar microtubules are microtubules that extend from the centrosome 
and interdigitate with each other in an anti-parallel manner at the equator of 
the bipolar spindle to provide structure and support. These non-kinetochore 
microtubules  are the most abundant subset of microtubules found within the 
spindle and are very dynamic, with a half-life of ~50 seconds (Zhai et al., 
1995). The kinetochore fibers (k-fibres) are the third class of microtubules 
found in the mitotic spindle. They are composed of ~20-25 bundled parallel 
microtubules that attach the chromosomes to the spindle poles, thus allowing 
the sister chromatids to be separated into new daughter cells (Rieder, 1981, 
McEwen et al., 1997). These K-fibers are more stable than the interpolar 
microtubules, with an average half-life of ~6 minutes (Bakhoum et al., 2009, 
Zhai et al., 1995).  
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Figure 1. 5: Microtubule components of the bipolar spindle.  
The Astral MTs extent out towards the cell cortex and do not play a crucial role 
in cell division, but important for spindle positioning. The interpolar MTs 
provide structure and stability to the bipolar spindle. The kinetochore MTs are 
essential for mediating attachment to the chromosomes. Adapted from 
Auckland & McAinsh, 2015.  
 
 
 
In order for cell division to occur, the bipolar spindle needs to be established 
and then maintained throughout Mitosis. To establish the bipolar spindle, 
balanced forces exerted on the microtubules by molecular motors are needed. 
As previously described, the Kinesin-5, Eg5 is crucial for establishing the 
bipolar spindle by separating the duplicated centrosomes. In the absence of 
Eg5, Kif15 overexpression can compensate and establish the bipolar spindle, 
as both these motors exert the outward pulling forces required for the 
establishment of the bipolar spindle (Vanneste et al., 2011, Vanneste et al., 
2009, Tanenbaum et al., 2009). However, Kif15 overexpression-dependent 
bipolar spindle assembly requires Tpx2 (Mann et al., 2017). Centrosome 
separation also requires the presence of minus-end directed motors such as 
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dynein and the Kinesin-14 HSET, which provide the inward pulling forces to 
balance the forces exerted (Sharp et al., 2000, Tanenbaum et al., 2008). This 
has been confirmed by depletion experiments in cells, whereby removal of  
Eg5 resulted in the formation of a monopolar spindle and the subsequent 
depletion of dynein restored the bipolar spindle (Tanenbaum et al., 2008) 
 
In HeLa cells, Eg5 inhibition using Monastrol does not affect the maintenance 
of the bipolar spindle as Kif15 is able to compensate and provide the outward 
pulling forces required to maintain the bipolar spindle (Vanneste et al., 2009). 
However, when the cells where depleted of both plus-end directed motors, the 
spindle collapsed into a monopolar state. If Dynein was then removed in a Eg5 
and Kif15 depleted background, the bipolar spindle was re-established 
however there was an increase in chromosome misalignments (van Heesbeen 
et al., 2014).  This suggests that force balance is also important in mediating 
correct kinetochore-microtubule attachments.  
 
Despite the requirement of overexpression of Kif15 to assemble the bipolar 
spindle in the absence of Eg5, basal levels of Kif15 are enough to maintain 
the established bipolar spindle. Also, due to the localisation of Kif15 to the k-
fibres which it also stabilises (Sturgill and Ohi, 2013) it may be that these 
microtubules are crucial in mediating Kif15-dependent bipolar spindle 
assembly. The Ohi lab investigated this and established that not all human 
cells respond the same to Eg5 depletion. In fact, the ability of the cells to use 
the Kif15-dependent bipolar spindle assembly is largely dependent on the 
stability of the k-fibres in the cells. In HeLa cells, the k-fibres are very stable 
and in the absence of Eg5, Kif15 is able to maintain the bipolar spindle. 
However, in cells such as RPE cells, the k-fibres are less stable and in the 
absence of Eg5, Kif15 is not able to re-establish the bipolar spindle (Gayek 
and Ohi, 2014).  
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Figure 1. 6: Force balance model for bipolar spindle assembly.  
Eg5, Kif15 and Dynein localise to over-lapping microtubules to generate 
balanced forces required. In the absence of Eg5 and Kif15, the excessive 
inward force generated by Dynein results in the formation of a monopolar 
spindle. In the absence of Dynein, Eg5 and Kif15 produce excessive 
outward force. In the absence of all three motors, the bipolar spindle is 
able maintain its configuration, however, there is an increase in 
chromosome misalignments.  
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1.3.3 Non-mitotic function for Kinesin-12 motors 
 
Despite the crucial role of Kif15 in mitosis, the is some evidence that the motor 
can perform several non-mitotic functions. Kif15 has recently been shown to 
play a role integrin trafficking. Specifically, it was found that a2 integrin 
trafficking is inhibited by Kif15 (Eskova et al., 2014). This is promoted through 
Kif15-dependent localisation of the clathrin adaptor, Dab2 to the plasma 
membrane. This suggests that Kif15 may function as a transport Kinesin in 
interphase. 
 
Kif15 plays an important role in mediating cell migration in post-mitotic neurons 
and axonal growth. Depletion of Kif15 also causes uncontrolled axonal growth, 
decrease in axonal branching and growth cone size (Liu et al., 2010). Kif15 
phosphorylation of T1142 mediates its interaction with myosin-IIB, which has 
been shown to promote astrocyte migration (Feng et al., 2016). One possibility 
is that these effects of cell migration are a consequence of the reported 
interaction between Kif15 and actin (Liu et al., 2010). Further work will be 
needed to determine the interaction between Kif15 and actin, and how this 
contributes to cell migration. 
 
Interestingly, Kif15 has also been revealed to be involved in remodelling the 
actin cytoskeleton during infection. This idea came from yeast two-hybrid 
experiments that found an interaction between C-terminal end of Kif5 
(residues 1092-1347) and EspW, an effector of the type III secretion system 
of bacterial cells (Sandu et al., 2017). EspW has been found to mediate actin 
dynamics of infection sites using a RAC1-dependent mechanism. EspW 
interacts with Kif15, which in turns activates Rac1 that is required to remodel 
the actin cytoskeleton to respond to an infection.  
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1.4 Project Outline   
 
There are conflicting views in the field regarding the structural organisation of 
Kif15, as it has been found that Kif15 functions as a tetramer (Drechsler et al., 
2014, Mann et al., 2017) as well as a dimer (Sturgill et al., 2014). Also, the 
exact structural assembly of Kif15 remains unknown and whether the tetramer 
is bipolar or parallel is also yet to be elucidated. To fully understand the role 
of Kif15 and its functional redundancy with Eg5, a clear understanding of its 
structural assembly is required (Hancock, 2014). Also, the mechanism by 
which Kif15 autoinhibits at a structural level remains uncovered.  
 
In this project, we have successfully been able to provide a detailed 
understanding of the structural assembly of Kif15 into a tetramer. Also, 
presented here is an understanding of the effect on the structure of Kif15 when 
the C-terminal leucine zipper is absent. Finally, we have also uncovered the 
molecular mechanism by which Tpx2 inhibits Kif15.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 27	
Chapter 2: Materials and Methods 
 
2.1 Molecular Biology 
 
2.1.1 CRISPR genome-editing 
 
CRISPR genome editing was used to generate RPE1-mCherry-Tubulin cells 
depleted of Kif15. The protocol was followed as described in Ran et al., (2013). 
A 20 small guide RNA nucleotide sequence, 5’ 
GGTGAGGGCGCTATGGCACC 3’ was used to target the Cas9 to the Kif15 
genome sequence. The Cas9 enzyme cuts between the 17th and 18th base of 
the guide sequence, which corresponds to the 5th and the 6th nucleotide of 
Kif15 exon 1. This nucleotide sequence is only found once within the human 
genome, thus minimizing off-target effects.  
 
The sgRNA sequence was cloned into pSpCas9-2A-GFP plasmid (Addgene 
plasmid ID:48138) using primers 5' CACCGGGTGAGGGCGCTATGGCACC 
3' and 5' AAACGGTGCCATAGCGCCCTCACCC 3'. This plasmid was then 
transfected into RPE1-mCherry-Tubulin cells as described in 2.2 Plasmid DNA 
Transfection. After 48-hour transfection, the cells were prepared for cell 
sorting. The transfected cells were trypsinised, spun at 200 g for 5 mins and 
replaced with starving media (Sigma dulbecco’s modified Eagle’s medium F-
12 Ham 1 % FBS (Sigma), 1 % Penstrep (Sigma) and 2 mM L-Glutamine 
(Sigma)) and sorted using a BD influx FACS cell sorter (Bioscience) to enrich 
for transfected cells. The cells were then seeded for single clones using 1000 
cells in a 20 cm dish. The sorted cells were replaced with standard RPE1 
media (Sigma dulbecco’s modified Eagle’s medium F-12 Ham 10 % FBS 
(Sigma), 1 % Penstrep (Sigma) and 2 mM L-Glutamine (Sigma)). The cells 
were allowed to expand for 2-3 weeks and single clones were selected using 
cloning discs (Sigma). The cells were then grown in a 24-well plate and 
passaged for immunofluorescence screening (see section 2.5.3 
immunofluorescence for more details) 
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2.2 Cell Biology 
 
2.2.1 Mammalian Cell Maintenance 
 
RPE1-mCherry Tubulin cells (Gift from Straube Lab), were cultured in Sigma 
dulbecco’s modified Eagle’s medium F-12 Ham 10%FBS (Sigma), 
1%Penstrep (Sigma) and 2mM L-Glutamine (Sigma) and grown in a 37% 
humidified incubator with 5% CO2. To maintain the cells, they were grown until 
80% confluency, washed with PBS then split using 1:1000 Trypsin. To check 
the cells have become detached, an inverted microscope was used, followed 
by a 1:10 dilution of the cells into pre-warmed RPE media. 
 
2.2.2 Plasmid DNA Transfection 
 
For plasmid DNA transfection, 750 µl Optimem (Gibco) and 10 ug DNA were 
separately mixed and incubated for 5 minutes, and 750 µl Optimem and 30 µl 
Fugene (Promega) were also mixed and left for 5 minutes. After this incubation 
period, both tubes were mixed together and left to homogenise for 30 minutes 
before adding to the cells. During this incubation period, the media in cells 
seeded in the 10 cm plate were replaced with fresh pre-warmed medium.   
 
2.2.3 Insect Cell Maintenance and transfection 
 
SF9 cells (Invitrogen) were grown in SF900 serum free media, containing 100 
U/ml Penicillin (Sigma), 100μg/ml Streptomycin (Sigma). The cells were grown 
at 280C and 105 rpm shaking incubator. The cells were allowed to reach a 
density of 1.5x106 cells/ml, before they were split 1:3 into fresh SF900 media.  
SF9 cells were re-suspended to a final density of 1x106 in 24 well-plate. 
Transfection of SF9 cells with DNA was carried out using the BacMagic DNA 
Kit (Novagen) as described in the user manual; 12 µl Escort IV (Sigma), 5 µl 
vector DNA, 5 µl BacMagic DNA and 1 ml SF900 media were mixed well and 
incubated for 30 minutes before adding to the cells. After 5-7 days, the cells 
were spun at 400 g for 5 minutes, and the virus-containing supernatant is 
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filtered through a 0.45μm filter to collect the passage 1 (P1) virus stock. SF9 
cells at a density of 0.5x106 were infected with 50 µl of P1 virus. After 36 hours, 
the cells were spun down and re-suspended with SF900 media, 20% FBS and 
10% DMSO. The cells were then collected as 500 µl aliquots and stored in -
800C.These cells are henceforth referred to as Baculovirus Infected Insect 
Cells (BIICs). 
 
 
2.3 Biochemistry 
 
2.3.1 Protein Expression 
 
Protein expression was carried out by infecting SF9 cells with BIICs cells and 
1 ml aliquots of the cells were taken every 24 hours for 96 hours then ran on 
a hand-cast 10% SDS-PAGE gel followed by western blotting to determine 
optimal protein expression. For the western blotting, the Penta-His monoclonal 
antibody (Thermo Scientific) was used at a concentration of 0.1 µg/mL. The 
protein was transferred onto a PVDF membrane (pre-activated using 100% 
methanol for 1 minute) for one hour using 20V. The membrane was then 
blocked for one hour, using 5% milk in BSA, followed by incubation with 
primary Penta-His monoclonal antibody (in 1.5% milk and TBST). The 
membrane was washed three times with TBST for 10 minutes each, followed 
by incubation with secondary anti-mouse Horseradish-Peroxidase (HRP) 
Antibody (Thermo Scientific). The signal was detected using the 
Chemiluminescent ECL Western Blot Kit (Biorad), following the manufacturers 
protocol.  
 
For large scale protein expression, 500 ml SF9 cells at 1x106 were infected 
with 500 µl of the BIICs stocks then left for 96 hours as done in Wasilko et al., 
2009). The cells were then harvested at 96 hours by spinning at 1200 rpm for 
20 minutes using an ss-34 rotor. The wet weight of the cell pellet was 
determined on a standard analytical balance and the pellet was resuspended 
in 4 ml per gram of cell pellet using SF9 lysis buffer (see table 2.1), containing 
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0.1 mM ATP, EDTA-free protease inhibitor (Roche), 1 mM DTT. The lysate 
was snap-frozen in liquid nitrogen and stored in -800C.  
 
SF9 Lysis Buffer 
50 mM HEPES, pH 7.55 
150 mM NaCl 
1.5 mM MgCl2 
3mM EGTA 
5% Glycerol 
0.1% Tween 
 
Table 2.1: SF9 Lysis Buffer.  
  
 
2.3.2 Protein Purification 
 
For Kif15 purification, a two-step method was used as described in Drechsler 
et al., 2014. The lysate was spun at 20 0000 rpm for 30 minutes in an ss-34 
rotor, followed by 1:3 dilution of the supernatant in 50 mM Sodium Phosphate 
buffer. 10 ml SP sepharose beads (Sigma) were loaded onto gravity columns 
and pre-equilibrated using 3 bed-volume of SP equilibration buffer. The beads 
were then incubated with the supernatant and placed on a mixer roller for 2 
hours. Next, the supernatant was eluted using gravity flow. 1.5 bed-volume 
SP wash buffer 1 was used to elute protein of the column. At the same time 1 
ml Talon beads were pre-incubated in 3 bed-volume talon beads equilibration 
buffer. The sample was then mixed with the talon beads and 10 mM imidazole 
was added and allowed to incubate for 2 hours. The talon beads were washed 
using Talon wash buffer 1 (20 bed-volume) and 2 (30 bed-volume), and the 
protein was eluted as 300 µl fractions from the beads using Talon elution 
buffer.  
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SP Equilibration Buffer SP Elution Buffer 
50 mM Sodium Phosphate (pH 7.0) 
50 mM Sodium Chloride 
1 mM MgCl2 
0.05% Tween20 
5% Glycerol 
0.1 mM ATP 
 
50 mM Sodium Phosphate (pH 7.5) 
50 mM Sodium Chloride  
1 mM MgCl2 
0.05% Tween20 
5% Glycerol 
0.1 mM ATP 
 
Talon Equilibration Buffer Talon Wash Buffer 1 
50 mM Sodium Phosphate (pH 7.5) 
100 mM Sodium Chloride 
1 mM MgCl2 
5% Glycerol 
0.05% Tween20 
0.1 mM ATP 
50 mM Sodium Phosphate (pH 7.5) 
300 mM Sodium Chloride  
1 mM MgCl2 
0.05% Tween20 
5% glycerol 
0.1 mM ATP 
 
Talon Wash Buffer 2 Talon Elution Buffer 
50 mM Sodium Phosphate (pH 7.5) 
100 mM Sodium Chloride 
1 mM MgCl2 
0.05% Tween20 
5% glycerol 
0.1 mM ATP 
10 mM imidazole 
 
50 mM Sodium Phosphate (pH 7.5) 
150 mM Sodium Chloride  
1 mM MgCl2 
10% Glycerol 
0.1 mM ATP 
50 mM imidazole 
 
 
Table 2.2: Kif15 purification buffers.  
 
 
For the Tpx2 purification, again, the protocol was followed as described in 
Drechsler et al., 2014. The lysate was spun at 20000 rpm for 30 minutes using 
an ss-34 rotor. The supernatant was diluted 1:3 using 50 mM Sodium 
Phosphate buffer. 10 ml SP beads were equilibrated using 3 bed-volume of 
SP equilibration buffer, followed by being mixed with the supernatant and 
incubated for 2 hours. Next, the SP beads were washed using SP wash buffer 
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1 (5 bed-volume) and eluted using SP wash buffer 2 (3 bed-volume). 1 ml 
talon beads were equilibrated using 3 bed-volume talon equilibration buffer, 
mixed with the sample and 10 mM Imidazole and incubated for 2 hours. The 
beads were washed using Talon wash buffer (50 bed-volume) and eluted as 
300 µl using the Talon elution buffer. All proteins were quantified using image 
J with a BSA standard curve and Bradford assay.  
 
 
SP Equilibration Buffer SP Wash Buffer 
50 mM Sodium Phosphate (pH 7.5) 
50 mM Sodium Chloride  
1 mM MgCl2 
0.05% Tween20 
5% Glycerol 
 
50 mM Sodium Phosphate (pH 7.5) 
100 mM Sodium Chloride  
1 mM MgCl2 
0.05% Tween20 
5% Glycerol  
SP Elution Buffer Talon Equilibration Buffer 
50 mM Sodium Phosphate (pH 7.5) 
300 mM Sodium Chloride  
1 mM MgCl2 
0.05% Tween20 
5% Glycerol 
 
 
50 mM Sodium Phosphate (pH 7.5) 
100 mM Sodium Chloride  
1 mM MgCl2 
5% Glycerol 
0.05% Tween20 
 
Talon Wash Buffer  Talon Elution Buffer 
50 mM Sodium Phosphate (pH 7.5) 
150 mM Sodium Chloride 
1 mM MgCl2 
10% Glycerol 
10 mM imidazole 
0.05% Tween20 
 
50 mM Sodium Phosphate (pH 7.5) 
75 mM Sodium Chloride  
1 mM MgCl2 
10% Glycerol 
150 mM imidazole 
 
 
Table 2.3: Tpx2 purification buffers.  
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2.3.4 In-vitro tubulin polymerisation 
 
Tubulin prep from previous members of the McAinsh lab was used. 8 µl of 72 
µM Tubulin were mixed with 2 µl of 100 mM GMP-CPP, 10 mM DTT and 8 µl 
BRB80 buffer (table 2.4). The sample was then incubated on ice for 30 
minutes, followed by a 1 hour 37oC incubation. To remove free tubulin, 
microtubules were spun in an airfuge for 5 mins and washed with pre-warmed 
BRB80 to 20 µl final volume. Taxol was added at a final concentration of 10 
µM.  
 
 
 
 
 
Table 2.4: Composition of BRB80 buffer. 
 
 
 
2.4 Cross-linking Mass Spectrometry 
 
2.4.1. BS3 Cross-linking 
  
Bis(sulfosuccinimidyl)suberate (BS3) (Thermo Scientific – catalog number: 
21580) was freshly prepared each time by dissolving 1.43 mg of BS3 in 100 
µl conjugation buffer (see table 2.4) to obtain a BS3 stock concentration of 25 
mM. For monomeric cross-linking 200 µM of BS3 for 2 µM for the protein of 
interest was used. For dimeric cross-linking 3 mM of BS3 for 2 µM protein was 
used. Tetrameric cross-linking was achieved using 5 mM BS3 for 2 µM protein. 
The reaction was Incubated at 23°C for 1 hour in a thermomixer using 500 
RPM and quenched with 1 M TRIS pH 7.5 to a final concentration of 50 mM. 
BRB80 Buffer 
80 mM PIPES pH 6.8 
1 mM MgCl2, 
1 mM EGTA 
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The protein complexes were then separated on either SDS-PAGE or Native-
PAGE gels, or taken directly to the tryptic digestion.  
 
 
 
 
 
 
 
 
 
Table 2.5: BS3 conjugation buffer used.  
 
For isotopic BS3, the BS3-d0 and BS3-d12 come in pre-weighed 1:1 mixed 1 
mg aliquots. The powder was dissolved in conjugation buffer to obtain 25 mM 
BS3 d0/d12 stock concentration. For BS3 d0/d4 cross-linking, 1 mg BS3-d4 
powder was dissolved in conjugation buffer to obtain 25 mM stock 
concentration. The BS3-d0 and BS3-d4 are mixed 1:1 to obtain a 25 mM stock 
of BS3 d0/d4. 
 
2.4.2 EDC Cross-linking 
 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) (Thermo 
Scientific - catalog number: 22980) was dissolved in deionized water to obtain 
a stock concentration of 25 mM. For the EDC cross-linking experiments, the 
addition of Sulfo-NHS (Thermo Scientific) dissolved in deionized water was 
added to optimise cross-linking conditions by further stabilising the amine-
reactive intermediates.  
 
BS3 Conjugation Buffer 
20 mM Sodium Phosphate buffer pH 7.5 
50 mM NaCl 
1 mM EGTA 
1 mM MgCl2 
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For the EDC cross-linking experiments for Tpx2 and Kif15 in the absence of 
microtubules, 2.5 µM dimeric Tpx2 and 80 nM tetrameric Kif15 stored in their 
purification buffer was found as the optimal protein concentrations to be used 
after titration experiments. The proteins were incubated with 6 mM EDC/Sulfo-
NHS which was found as the optimal cross-linking concentration and 
quenched for 30 minutes using 1 M TRIS pH 7.5 at a final concentration of 50 
mM. A standard in-solution digest protocol was then followed.  
 
For the EDC cross-linking experiments in the presence of microtubules, 33 nM 
dimeric hTpx2 and 16.5 nM tetrameric hKif15 were first incubated for 10 
minutes with 5 µM microtubules stabilized using GMP-CPP (Jena Bioscience) 
and in the presence of 2 mM AMP-PNP (Sigma) to enable the kinesin to lock 
onto the microtubules. The sample was then spun at 13000 r.p.m on a 
microcentrifuge, to remove unbound Kif15, Tpx2 and free tubulin subunits. The 
sample was then cross-linked with 3 mM EDC/Sulfo-NHS for 1 hour and 
quenched for 30 minutes using 1 M TRIS pH 7.5 at a final concentration of 50 
mM.  
 
2.4.3 DSSO cross-linking 
 
For disuccinimidyl sulfoxide (DSSO) (Thermo Scientific – catalog number: 
A33545) cross-linking, DSSO was dissolved with DMSO to 50mM stock. 
Before cross-linking the protein, the sample was buffer exchanged 3 times to 
50 mM sodium phosphate buffer using Amicon Ultra Filter (Merck Millipore). 2  
µM Kif15 was cross-linked using 1 mM DSSO, followed by quenching using 1 
M TRIS pH 7.5 at a final concentration of 50 mM. The sample was then 
desalted using Amicon Ultra filters (30 Kda cut-off), followed by a standard in-
solution digest. 
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2.3.4 Sample Digestion and LC-MS Method 
For an in-gel digestion, the protein sample band was excised from the gel and 
washed with 50% ethanol in 50 mM ammonium bicarbonate for 20 minutes, 
followed by gel dehydration using 100% ethanol for 5 minutes.  The disulfide 
bonds were reduced by adding 10 mM DTT in 50 mM ammonium bicarbonate 
for 60 minutes at 57ºC and cysteine  residues were alkylated using 55 mM 
iodoacetamide (or chloroacetimide) in 50 mM ammonium bicarbonate for 20 
minutes in the dark. 2.5 ng/μL Trypsin (Sequencing grade; Promega) per 
protein band was used overnight at 37 ºC. To extract the peptides from the gel 
pieces,  5% formic acid in 25% acetonitrile was added followed by 5 -10 min 
sonication. This step was repeated three times. The peptide supernatant  was 
dried overnight at 40 °C using a Speed-Vac. The sample was then re-
suspended in 2.5% acetonitrile containing 0.05% trifluoroacetic acid and 
sonicated for 30 minutes. Finally, the sample was centrifuged at 17,000 g for 
5 mins. 
For an in-solution digestion, the sample was diluted using in 50 mM 
ammonium bicarbonate. This was followed by cysteine reduction using 1mM 
DTT for 60 minutes and alkylation using 5.5mM iodoacetamide in the dark for 
20 minutes. Lys-C digestion (1µg per 100 µg protein) was done for 3 hours at 
room temperature, followed by Trypsin digestion (1µg per 100 µg protein) 
overnight at 37 ºC. The sample was then de-salted using C18 stage tips 
(Rappsilber et al., 2007).  
For analysis by mass spectrometry, an UltiMate® 3000 HPLC series was used 
for peptide concentration and separation. Samples were separated in Nano 
Series™ Standard Columns. The gradient used was from 3% to 35% solvent 
B (0.1% formic acid in acetonitrile) for 30 min, followed by 35% to 70% solvent 
B for 20 min and finally 70% to 90% solvent B for 30 min. Peptides were eluted 
directly (~ 300 nL min-1) via a Triversa Nanomate nanospray source into a 
Thermo Orbitrap Fusion mass spectrometer. Survey scans of peptide 
precursors from 350 to 1500 m/z were performed at 120 K resolution (at 200 
m/z) with automatic gain control. (AGC) 4x105. Precursor ions with charge 
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state 2–7 were isolated and subjected to HCD fragmentation in the Orbitrap at 
15 K resolution and recorded in centroid mode. MS/MS analysis was 
performed using collision energies 25, 30 and 37, AGC 1x104 and max 
injection time 200 ms. The dynamic exclusion duration was set to 45 s with a 
10 ppm tolerance for the selected precursor and its isotopes. Monoisotopic 
precursor selection was turned on. The instrument was run in top speed mode 
with 2 s cycles.  
 
 
2.3.5 Mass Spectrometry analysis parameters 
 
MS2 spectra peak lists in a Mascot Generic Format (mgf) files were generated 
using the Xcalibur raw files, which are used for the subsequent analysis steps. 
 
To analyse the data, MASCOT search engine was used to confirm the 
presence of the proteins in the sample. Table 2.6 summarises the search 
parameters used. To search the data, mascot generic format (mgf) files are 
required.  
Enzyme Trypsin 
Missed cleavages 3 
Fixed modifications Carbamidomethylation 
Variable modifications Methionine oxidation 
Peptide tolerance (+/-) 20 ppm 
MS/MS tolerance (+/-) 20 ppm 
Peak type Monoisotopic 
 
Table 2.6: Search parameters used for MASCOT.  
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To analyse the cross-linked peptide, the software Stavrox (version 3.5.1) was 
used (Gotze et al., 2012). Presented in table 2.7 are the search parameters 
used. An mgf file of the MS2 spectra peak list and the fasta file for the protein 
sequence of interest were used as the input files.  
 
Protease Trypsin 
Missed cleavages 3 for Lysine and 1 for Arginine 
Minimum peptide length 4 
Fixed modification Carbamidmethylation 
Variable modification Methionine oxidation 
BS3-OH (Lys), BS3-NH2 (Lys)  
 
Cross-linker BS3 or EDC 
Precursor precision (+/-) 20 ppm 
Fragment ion precision (+/-) 20 ppm 
Ion Type  b and y ions 
Deisotoping yes 
Losses Neutral loss of all fragments 
 
Table 2.7: Stavrox software search parameters used.  
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To quantitatively analyse the cross-linked peptides, the label-free quantitation 
(LFQ) of MaxQuant was used. Most of the parameters were left as default, 
alterations are presented in table 2.8 for the specific search parameters for the 
LFQ module.  
 
 
LFQ minimum ratio count 2 
LFQ minimum number of 
neighbours 
3 
LFQ average number of 
neighbours 
6 
Match type Match to and from file 
Mass tolerance +/- 10 ppm 
Time tolerance  +/- 1 min 
Time tolerance for label +/- 1 min 
 
 
Table 2.8: MaxQuant LFQ search parameters used.  
 
 
To normalise the LFQ values, a standard MaxQuant search was done to 
obtain the three most abundant linear peptides for each of the samples. An 
average intensity for these peptides were used to normalise the intensity of 
cross-linked peptides. 
The DSSO cross-linked peptides were analysed using the DSSO module of 
Proteome Discoverer (version 2.2).  
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2.5 Microscopy 
 
2.5.1 TIRF Microscopy 
 
For the single molecule experiments, the flow chamber was created using 
double-sided scotch tape placed on top of a glass slide. The Sialylated 
coverslips were prepared as stated in (Bechstedt et al., 2011). The 
experiments were carried out using GMP-CPP (Jena Bioscience) stabilized 
Alexa-488 microtubules (Cytoskeleton). The flow chamber was blocked with 
1% Pluronic F-127 (Sigma-Aldrich) and 1 mg/ml kappa casein, followed by 
anti-beta tubulin antibodies (TUB 2.1, Sigma-Aldrich) used to adsorb the 
microtubules to the surface. The sample mix as stated in table 2.9 was flown 
into the chamber, which was sealed with VALAP (vaseline, lanolin, paraffin 
mixed 1:1:1). 
 
Sample Mix 
10 nM mKate2-Tpx2 
0.1 mg/ml kappa casein 
80 µg/ml glucose, 
40 µg/ml glucose-oxidase 
16 µg/ml catalase 
1 mM DTT 
50 mM KCl 
 
 
 
Table 2.9: Sample mix used for single molecule assays.  
 
The sample was imaged at 25°C on an Olympus CELLR/TIRF microscope 
(Olympus) using a 100x NA 1.49 objective with 1.6x additional magnification 
and 488 nm, and 640 nm lasers. An ImagEM emCCD camera (Hamamatsu 
Photonics), with an environmental chamber and a stage-top-incubator 
(Okolab).  3-min time-lapse videos were recorded at 2 frames per second (fps) 
with a 100 ms exposure.  
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2.5.2 Negative stain electron microscopy 
 
 
Formvar and carbon coated grids (300 mesh) were glow-discharged using an 
ELMO glow-discharge system (Cordouan) at 10 mA for 30 seconds. 5 µl of 
Kif15 was added at 1-2 µM concentration. The sample was incubated on the 
grid for 60 seconds before any excess was blotted off the grid using filter 
paper. The sample was stained using 5 µl of 0.7-2% uranyl acetate. The 
excess stain was blotted using filter paper. The sample was visualised using 
the JEOL 2011 microscope with Gatan Ultrascan 4000 CCD camera used for 
data imaging and collection.  
 
2.5.3 Immunofluorescence and fixed cell imaging 
 
 
For immunofluorescence, the AKIN-13, Anti-Hkpl2 polyclonal antibody 
(Cytoskeleton), was used and the method was followed as described in the 
manufacturers protocol; the cells were fixed with 100% Methanol at -200C for 
3 minutes. The cells, were washed once with PBS at room temperature for 30 
seconds, followed by a blocking step using 3 % Bovine serum albumin (BSA) 
for one hour, and another PBS wash step. 200 µl of 1 µg/ml (1:250) dilution of 
the Hklp2 antibody in blocking solution was added to the coverslips and 
incubated for one hour. The coverslips were then washed three times using 1 
% Triton X-100 for 5 minutes per wash. 200 µl of 1:500 dilution of the 
secondary rhodamine-conjugated anti-rabbit antibody was added and 
incubated for 30 minutes. The fixed cells were then washed three times with 
PBS and counterstained with DAPI (Invitrogen)  for 5 minutes with 200 µl of 
100 nM DAPI in PBS and mounted using Vectashield antifade mounting 
medium (Vector laboratories).  
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Fixed cells were imaged using a 1000x oil NA 1.4 objective on an Olympus 
Deltavision microscope (Applied Precision, LLC), connected to the imaging 
software SoftWorx (Applied Precision). Samples were imaged using the GFP 
channel (32%), mCherry channel (32%) and DAPI channel (10%). 
Approximately 64 z-slices were taken separated by 200 nm (covering a total 
z-distance of 12.8 μm). All images acquired were deconvolved and projected 
using SoftWorx.   
2.6. General analysis and figure preparation 
  
All graphs were generated using OriginPro, Excel or outputted using the mass 
spectrometry software used (Stavrox, MaxQuant and Proteome Discoverer). 
All figures were prepared using Adobe Illustrator. 
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Chapter 3: Development of a Cross-Linking 
Mass Spectrometry Workflow 
 
3.1. Introduction  
 
In the last decade, a new technique combining chemical cross-linking and 
mass spectrometry (XL-MS) has emerged as a very powerful technique to 
study protein topologies and protein-protein interaction networks (Sinz, 2006). 
XL-MS works by chemically cross-linking amino acids using a bifunctional 
reagent that captures protein interactions in their native state. The reagent 
usually cross-links lysine residues and has a functional distance that can be 
used to inform about the space between the cross-linked residues (Rappsilber, 
2011, Merkley et al., 2013). After cross-linking, the protein is subjected to 
proteolysis, typically using trypsin that cleaves at lysine and arginine residues, 
to generate a set of non-overlapping peptides. Resultant peptides are 
identified using liquid chromatography and mass spectrometry to determine 
the exact amino acids involved in the cross-linking. XL-MS is a very useful 
technique for providing detailed understanding of the precise interactions sites 
of proteins, and it is often used in combination with techniques such as Cryo-
EM to obtain a high resolution 3D structure of proteins and protein complexes 
(Schmidt and Urlaub, 2017). XL-MS is less time consuming than other 
techniques such as Cryo-EM and also is better in providing structural 
information of flexible regions that is not easily obtained with higher resolution 
techniques. Also, XL-MS can be used to study the conformational changes 
induced upon protein binding using quantitative cross-linking techniques 
(Schmidt and Robinson, 2014).  
 
Mass spectrometry analysis for the identification of peptides is usually done 
using tandem mass spectrometry (MS/MS).  During MS/MS, molecules are 
analysed in consecutive steps. Firstly, the intact protein is digested using a 
protease such as Trypsin. The digested peptides, which contain linear 
peptides and cross-linked peptides are separated using a reverse phase C18 
chromatography column followed by electrospray ionisation to generate 
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positively charged peptide ions which are injected into the mass spectrometer.  
The first mass spectrometer analyser step (MS1) is used to generate intact 
precursor ion masses of a specific m/z range and these ions are selected for 
subsequent peptide fragmentation. These fragmented ions are selected and 
analysed in a second mass spectrometer analyser step (MS2).  
 
Figure 3.1: Schematic overview of tandem mass spectrometry.  
A; First, a protein is digested to generate peptides. B; Digested peptides 
consist of linear peptides and cross-linked peptides. C; The digested peptides 
are separated on a reverse-phase C18 column, D; The peptides are ionised 
to generate positively charged precursor molecules and injected into the mass 
spectrometer. E; In MS1, the precursor ions are analysed and selected for 
peptide fragmentation. F; In MS2, the fragmented ions are selected and 
analysed. G; Mass spectra data is analysed to reveal the cross-linked 
peptides.  
 
 
The mass spectrometer instrument used was an Orbitrap Tribrid Fusion 
(Thermo Scientific). The Orbitrap fusion instrument has two separate 
detectors, the Orbitrap detector and the ion trap’s electron multiplier detector, 
which can be used at either MS1 or MS2 level. Also, the Orbitrap fusion 
instrument has three fragmentation modes; collision-induced dissociation 
(CID), high-collision dissociation (HCD) and electron-transfer dissociation 
(ETD). The Orbitrap detector works by inducing oscillations which are guided 
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by polarised detector plates. The oscillation regularity and spin varies 
depending on the mass/charge ratio of the ions (Makarov, 2000), with the 
signal transformed using Fourier transform to give a mass spectrum signal 
(Makarov, 2000). The components of the Orbitrap instrument are presented in 
figure 3.2. The s-lens is the first component, which focuses and enables the 
ions to be transmitted into a coherent ion beam. The curve in the ion beam 
improves signal/noise ratio by preventing uncharged molecules from travelling 
through to the quadrupole mass filter. The Quadrupole can allow all ions 
through or can select the precursor ions depending on the mass range set. 
Ions can be directed between different areas for fragmentation, to the Orbitrap 
detector, or to the linear ion trap’s electron multiplier detector. The selected 
precursor ions are then transported to the ion-routing multipole or the pressure 
cell of the ion trap for HCD or CID/ETD fragmentation, respectively.   
 
 
 
Figure 3.2: Overview of the Orbitrap Tribrid Fusion instrument.  
The first component, the s-lens is required to focus and transmit the ions into 
the ion beam. The curve of the ion beam reduces background signal by 
ensuring only the charged particles enter the quadrupole. The quadrupole 
selects precursor ions based on a pre-set mass range. MS1 analysis can be 
done using the Orbitrap detector or the linear ion trap’s electron multiplier 
detector. Selected precursor ions are fragmented using the ion-routing 
multipole or the pressure cell in the ion trap for HCD or CID/ETD 
fragmentation, respectively.  
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The Orbitrap Fusion mass spectrometer has been an excellent instrument to 
work with as it provides three types of fragmentation methods and two types 
of detector. The Fusion instrument is able to switch between high resolution 
and mass accuracy detection using the Orbitrap detector or faster speed and 
sensitivity, which is offered by the ion trap. The three different fragmentation 
modes offered are CID, HCD, and ETD. Depending on the fragmentation 
mode, the ions are fragmented in the Ion trap (CID, ETD) or the Ion-Routing 
Multipole (HCD) and generate different ion types (figure 3.3). 
 
Which type of fragmentation is best can depend on charge state, intensity and 
m/z value. The most commonly used fragmentation technique in proteomics 
is collision-induced dissociation (CID), whereby the precursor ions enter a 
collision cell and neutral gas molecules such as helium are introduced which 
collide with the precursor ions and generate vibrational energy. This vibrational 
energy induces amide bond fragmentation, which generates characteristic b 
and y ions, whereby the peptide charge is retained on the N-terminal or c-
terminal, respectively (figure 3.3). There are also neutral loss fragmentations 
that generate molecules such as water and ammonia associated with CID. 
CID fragmentation is ideal for short peptides with small charge states. Also, 
fragmentation of modified peptides, such as phospho-peptides, is not suitable 
using CID.  
 
Another technique that produces the same ion types as CID, is higher-collision 
dissociation (HCD). This technique is a very attractive technique for high 
resolution analysis, as the fragmentation ions are normally analysed using the 
Orbitrap detector instead of the ion trap. The ion trap is unable to detect the 
lowest 1/3 of m/z fragment ions, thus invaluable fragmentation data is lost. 
This is not the case for HCD fragmentation. Whilst HCD fragmentation 
produces b and y ions as well, there is a bias towards y ions than b ions and 
producing fragment ions of a lower charge state (Shao et al., 2014).  
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ETD fragmentation has more often been used to study post-translational 
modifications as it can acquire good sequence coverage whilst keeping the 
modification intact (Mikesh et al., 2006). This is because ETD does not use 
collision based fragmentation, but instead uses a radical anion to transfer an 
electrode to the positively charged precursor ion, which causes a cleavage in 
the N-Ca bond to produce c and z ions (figure 3.3). It has also been shown 
that ETD fragmentation works better for precursor ions of a higher charge state 
(Chalkley et al., 2010)  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 3: Peptide fragmentation ions.  
CID and HCD generates b and y ions, whereas ETD fragmentation generates 
c and z ions.  
 
The first stage of cross-linking mass spectrometry is selecting the cross-linker 
of choice. The most common cross-linker used is bis(sulfosuccinimidyl) 
suberate (BS3). This is a bifunctional cross-linker that can cross-link primary 
amines including lysine, serine, tyrosine and  threonine residues (Kalkhof and 
Sinz, 2008).  The cross-linker functions at physiological pH conditions between 
7-9 (Madler et al., 2009) and has a functional distance of 11.4 Å (figure 3.4). 
Using lysine residues as the reactive group for cross-linking is an attractive 
choice as lysine is one of the most abundant amino acids in protein 
sequences. Also, lysine residues are generally solvent accessible and 
exposed on the surface of protein structures. Isotope labelled BS3 cross-linker 
can also be used for cross-linking.  
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1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) cross-
linker that cross-links carboxyl group of amino acids such as aspartic and 
glutamic acid, to primary amines. Since this cross-linker has a spacer arm 
length of 0 Å (figure 3.4), it provides a more accurate idea of direct contact 
sites as the cross-links identified with EDC must all be within a salt-bridge 
distance (Rivera-Santiago et al., 2015). This is due to the EDC cross-linker’s 
generation of an unstable ester intermediate, which directly cross-links the 
carboxyl group to a primary amine. The specificity of a cross-linker molecule, 
whilst desirable a lot of the times, can also be a disadvantage. Due to EDC 
only interacting with N-terminal end of proteins, lysine, aspartic and glutamic 
acid, protein regions not enriched with these residues would be unable to 
generate cross-links. Also, proteins folded in such a way that these reactive 
groups are buried will also not be able to generate significant cross-links 
(Rivera-Santiago et al., 2015). EDC cross-linker is also not amenable to 
modifications such as isotope labels, thus this cannot be used a confidence 
filtering strategy.  
 
 
 
 
Figure 3. 4:Structures of different chemical cross-linkers used. 
BS3 is the most common cross-linker used in the literature. It is water soluble 
and has a spacer arm length of 11.4 Å. EDC is also water soluble however the 
spacer arm length is 0.0 Å. Shaded in purple are the regions of the reagent 
which disappear in the case of a successful cross-link. As is clear from this 
figure, the whole EDC reagent is not present in the final cross-linked product. 
Figure is adapted from Thermo Fisher Scientific. 
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Chemical cross-linking leads to the formation of three product types (figure 
3.5). The first type is the mono-linked peptide. This is when one reactive group 
side of the cross-linker cross-links to a peptide, but the second reactive group 
undergoes hydrolysis and the peptide becomes modified with an OH and NH2 
group, thus unable to form a second cross-link site. Particularly with BS3 
cross-linking, the generation of these mono-linked peptides are common as 
they undergo fast hydrolysis rates. However, due to the cross-linking 
chemistry of EDC cross-linkers, they are less likely to produce mono-linked 
peptides as in the absence of a primary amine group to cross-link to, the 
intermediate ester group reverts back to the stable carboxyl form (Rivera-
Santiago et al., 2015). This makes any downstream analysis easier to handle 
as the dead-end products can make up a significant portion of the data to be 
analysed. The second type is the loop-linked peptide, (intra-peptide bonds). 
This is when the cross-linker loops and cross-links residues within the same 
peptide. The third type and the most structurally informative product type 
associated with cross-linking is when two individual peptides are cross-linked 
by forming covalent bonds to either side of the bifunctional reagent (inter-
peptide bond).  
 
Figure 3.5: Product types associated with cross-linking mass 
spectrometry. A; When the cross-linker attaches to the peptide on one 
reactive site and undergoes hydrolysis at its second reactive group, this 
results in the formation of a mono-linked peptide. B; When a cross-linker 
cross-links two residues within the same peptide, this results in a loop-
linked peptide. C; For the cross-linked peptide, two peptides are tethered 
together using the cross-linker.  
 
Loop-linked peptide Cross-linked peptideMono-linked peptide
Single peptide Single peptide Two cross-linked peptides
A B C
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Depending on the chemical cross-linker and the product type formed, a 
different mass modification is produced, which is summarised in Table 3.1.  
 
Table 3.1: Mass modifications associated with cross-linking with BS3, 
stable isotope labelled BS3 and EDC cross-linkers.  
 
There are several types of mass spectrometry software used by the XL-MS 
community. Mascot software is a general peptide identification software used 
to analyse mass spectrometry data. The mascot search engine takes an input 
protein database in a fasta file format and tries to match peptide ions data 
gathered from the mass spectrometer. Specifically, the experimental ion 
masses are compared to a list of expected digested peptide and fragment ion 
masses calculated from the protein sequences provided in the fasta files. 
These masses are then scored according to how well they match. Mascot can 
also calculate the expected peptide and fragment ion masses associated with 
a digested peptide ion modified with a chemical group, such as 
phosphorylation or a mono-linked peptide. However, it cannot be used to 
calculate and identify the fragmentation of two digested cross-linked peptides. 
 
Stavrox is a leading software for the analysis of cross-linked peptides (Gotze 
et al., 2012).  Based on an in-silico digest of your protein sequence, the 
software calculates all possible theoretical cross-linked peptide candidates, 
and then calculates all possible b and y ion series for a given cross-link site, 
with the reactive groups associated with a particular cross-linker set as the 
default cross-link site. Both EDC and BS3 target lysine residues and since 
Cross-
linker 
Bifunctional cross-linked 
amide bond 
Mono-linked 
hydrolysis 
BS3-d0 138.067 amu 156.078 amu 
BS3-d4 142.092 amu 160.013 amu 
BS3-d12 150.143 amu 167.883 amu 
EDC -18.011 amu  
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trypsin is sensitive to steric hindrance, the analysis must permit an increase in 
the number of missed lysine- trypsin cleavage sites.  The Stavrox scoring 
algorithm is based on how well the expected and observed fragmentation ions 
match up. This scoring algorithm also takes into account the intensity of the 
fragment ions identified and how many high intensity peaks are unidentified, 
the S/N ratio of the spectra and how well each of the cross-linked peptides are 
fragmented and how long the fragment ion series are. In summary, in order to 
achieve a good Stavrox identification with a score ~100 the following criteria 
should be met: 
 
 
• Observed fragmentation ions within ~20 ppm of expected fragment ions 
• Fragmentation ion series observed for both peptides, specifically, those 
fragment ions that include the cross-linker and the attached second 
peptide  
• Fragmentation ions account for most of the high intensity peaks present 
in the spectra 
• Only a few high intensity signals unidentified in spectra 
• There is little noise in spectra  
 
 
The development of cross-linking mass spectrometry has become a very 
useful tool to probe the structural organisation of proteins and protein 
complexes. However, a major bottle-neck has become how to optimise the 
experimental design and the analysis pipeline. Although this technique is 
increasingly popular, there are only a handful of research groups such as 
Professor Albert Heck (Utrecht University, Netherlands), Professor Juri 
Rappsilber (University of Edinburgh, UK) and Professor Andrea Sinz (Martin 
Luther University Halle-Wittenberg, Germany) who routinely apply this method 
study protein topology.  
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The aim of this chapter was to produce an optimised cross-linking mass 
spectrometry protocol and analysis workflow. At the start of my project, the 
Orbitrap Fusion was a new state-of-the-art mass spectrometer, just purchased 
for the Proteomics facility, thus this required a lot of time to optimize cross-
linking conditions. Also, given that there is not a standard cross-linking 
analysis pipeline, a lot of time was spent on establishing an integrated 
software analysis workflow. Presented in figure 3.6 is an overview of a 
standard cross-linking mass spectrometry workflow. Highlighted with a star 
are the sections discussed in-depth in this chapter. Adjacent to the workflow 
are the optimisation experiments that were tested for the individual protocol 
steps to create a coherent cross-linking mass spectrometry analysis pipeline. 
 
Figure 3. 6: Cross-linking mass spectrometry workflow.  
On the left hand side is a typical workflow for cross-linking mass spectrometry. 
The stars indicate the steps discussed in this chapter. On the right hand side 
are the optimization experiments that were tested in order to obtain a 
standardized cross-linking mass spectrometry workflow.   
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3.2. Chemical cross-linking  
 
3.2.1 Chemical cross-linking  
 
The monomeric Kif15 cross-linked data will be presented in this chapter to 
provide examples of the method development workflow. Presented in table 3.3 
(p80) is the list of monomeric Kif15 cross-linked peptides identified.  
 
The two steps of the cross-linking mass spectrometry workflow that will not be 
discussed in depth in this chapter is the cross-linking set-up and the protein 
digestion steps which go hand in hand. As for the cross-linking setup, this has 
to be tailored for the experiment and the molecular weight of the complex 
expected, which will be further discussed in chapter 4. With regards to the 
protein digestion, depending on whether the cross-linking was separated on a 
gel or done in-solution, the digest was done accordingly.  
 
The cross-linked peptides analysis was started by doing a basic database 
search to identify the tryptic peptides of Kif15. The search engine of choice 
was Mascot. This software can search the identification of linear peptides 
through matching the expected peptide fragmentation masses to the observed 
masses acquired from the mass spectrometer. As only a portion of our protein 
will be cross-linked in any circumstance (Holding et al., 2015) we still expect 
to see a good sequence coverage for the protein, thus a good protein 
coverage is essential before any subsequent cross-linked peptides analysis. 
The protein coverage for the untreated and treated samples averaged at 75%. 
Also, as previously mentioned, Mascot is able to analyse and identify linear 
peptides and any modification associated with these peptides. However, it is 
not able analyse the fragmentation ions expected for two peptides cross-linked 
together.  
 
To prove that the cross-linking chemistry has occurred, we used the Mascot 
search engine to search against linear peptides of Kif15 which have been 
modified with a reactive group from the BS3 cross-linker.  This occurs when 
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the cross-linker attaches to a peptide on one end, however, the second 
reactive group undergoes hydrolysis, thus unable to form a second cross-link 
to another peptide. As this results in the formation of a linear peptide with a 
known mass modification of +156 Da, indicative of hydroxyl group modified 
mono-link (Schilling et al., 2003), which can easily be included in our Mascot 
search. For an average cross-linked sample, there were ~50 BS3 modified 
monolinked peptides identified. EDC does not generally produce mono-linked 
peptides, as the intermediate ester returns to its original carboxyl state when 
it is unable to cross-link to a primary amine (Rivera-Santiago et al., 2015). 
 
Presented in figure 3.7 is an example of a peptide 
(40SGSADGEQNLCLSVLSSTSLR60), modified at the Ser-52 with the BS3 
mono-link. Another modification seen is a mass of 57 Da added to the Cys-50 
residue. This is a common modification, as the cysteine residues are alkylated 
during the digestion protocol to prevent any cysteine cross-reactivity, and this 
added mass is indicative of the alkylation process.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7:Mono-linked peptide 40SGSADGEQNLCLSVLSSTSLR60.  
A; schematic showing the modified peptide with hydrolysed BS3. B; 
Annotated MS2 spectrum for the monolinked peptide 
40SGSADGEQNLCLSVLSSTSLR60, whereby the blue peaks indicate the y-
ions and the red peaks indicate the b-ions. The “S+156” indicates the addition 
A 
B 
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of the hydrolysed BS3 molecule to Ser-52. The “C+57” shows the modified 
mass associated with the cysteine alkylation of Cys-50.  
 
 
 
3.2.2 Different chemical cross-linkers for cross-linked peptides analysis 
 
As BS3 and EDC have difference spacer lengths (11.4 Å and 0 Å, 
respectively), they provide different information on residue proximity. 
Specifically, BS3 cross-links indicate residues which are within a 11.4 Å 
distance whereas, EDC cross-links infer information about direct contact sites. 
Also, the reactive groups are not exactly the same. BS3 is a homo-bifunctional 
reagent, which reacts with primary amines, including lysine, serine, threonine 
and tyrosine residues. EDC is a heterobifunctional cross-linker that cross-links 
carboxylic acid containing residues such as aspartic acid and glutamic acid, 
to primary amines.  
 
With cross-linked peptides, you have two peptides bridged by a chemical 
cross-linker with a known mass. As such, the fragmentation of the cross-linked 
peptides can be calculated as being the mass of the first peptide with 
additional mass of the cross-linker and the second peptide that forms the 
cross-link. For simplicity, the longer peptide chain is called the “alpha peptide” 
whereas the shorter peptide is called the “beta peptide”. In order to confidently 
identify a cross-link, it is best to have as many fragments arising from both 
peptides. In particular, the fragments ions containing the additional mass of 
the cross-linker and the second peptide are crucial as they are the only way 
of confirming that the two peptides have indeed been cross-linked. Also, 
neutral losses from the fragments, such as water or ammonia molecules is 
often seen as well. 
 
Presented below in figure 3.8 is an example of the peptide 407DKK409 cross-
linked to 1035KQEVDILDLK1044 (K151), identified with both EDC and BS3. The 
BS3 precursor ion exists as a 3+ ion and the EDC ion is a 2+ ion. As the 
reactive groups are not exactly the same for these two cross-linkers, only the 
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cross-link identified in the alpha peptide is the same. For the beta peptide, the 
BS3 cross-links to the lysine residue whereas for the EDC example, the cross-
link is matched to the adjacent aspartic acid residue. As such, the modified 
mass associated with the cross-linker is not the same and since the cross-
linked residues are not the same, the masses of the fragment ions cannot be 
compared. However, there is a general pattern seen, whereby there is a 
continuous y ion series seen for the alpha peptide in both spectra. The BS3 
spectra also produced a continuous b ion series. Since the precursor ion for 
the BS3 cross-linked peptide was found at a higher charge state, there are 
more fragments identified for this spectra.   
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3.3 Mass Spectrometry Analysis – Impact of mass resolution 
on XL-MS Analysis 
 
The Orbitrap offers two detectors, the Orbitrap and the electron multiplier 
(located by the ion trap). These detectors have difference 
advantages/disadvantages in sensitivity, speed and resolution. Because 
cross-linked peptides are expected to occur at low overall abundance, we 
compared the performance of the low mass accuracy (but fast and sensitive) 
ion trap to the higher resolution (but slower and less sensitive) Orbitrap 
detector. MS1 level detection was done using the Orbitrap, however, the 
fragment ions at MS2 level was analysed using the Orbitrap and the electron 
multiplier detector.  
 
The use of the Orbitrap for the detection of MS2 fragment ions has significantly 
affected the accuracy and reliability for the detection of cross-linked peptides. 
Firstly, the fragment ions are detected with an accuracy of 20 ppm or less, 
thus increasing the reliability of the fragment ions identified (Leitner et al., 
2010). Also, the Orbitrap detector has an increased mass accuracy and 
resolving power, thus the isotope clusters for the fragment ions can be 
resolved more easily, thus these ions can be assigned a correct charge state 
and mass (Leitner et al., 2010).This increases the accuracy of the fragment 
ion annotation, thus increasing the reliability of the cross-linked peptides 
identified. A full width half maximum (FWHM) resolution of 120,000 was 
selected for the MS1 level, whereas a resolution of 15,000 was selected at the 
MS2 level. HCD fragmentation was used instead of CID, as HCD, is a method 
whereby fragmentation of the lower 1/3 of ions that are lost from the ion trap 
are retained. As such, fragments detected with HCD do not have a low m/z 
cut-off, much better resolution and increase in the number of detected ion 
fragments (Jedrychowski et al., 2011). Also cross-linked peptide identification 
using HCD instead of CID has been shown to improve peptide spectrum 
identification and the percentage of cross-linked peptides identified (Giese et 
al., 2016).  
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However, the use of high resolution detection using the Orbitrap does come 
with its disadvantages. The scanning rate per mass spectrum and detection 
time is much slower than the Ion trap, thus less fragments are detected (scan 
rate of 15 Hz and 20 Hz for the Orbitrap and Ion trap detectors, respectively). 
As such, it may affect the number of fragments that can be assigned for the 
cross-linked peptides. In figure 3.9, the same cross-linked peptide detected 
using the Orbitrap and the Ion trap is compared. In figure 3.9A and 3.9B are 
the fragmentation spectra of cross-linked peptides 884NLQNFKK890 and 
916LSLQFEEDK924 (K1513) identified using the Orbitrap and ion trap detectors, 
respectively. Adjacent to the fragmentation spectra is a visual representation 
of the fragments found for the cross-linked peptides. As is clear from the 
spectra for the ion trap detector, many more fragments ions are assigned to 
the cross-linked peptides. However, due to the higher error rate associated 
with these detected fragment ions, they are much less accurate than the 
Orbitrap detected fragments.  
 
As can be seen from figure 3.9C, irrespective of the m/z value of the detected 
fragments from the Orbitrap, the error of fragments detected is close to zero, 
when compared to the fragment ion error associated with the ion trap. This 
makes it more difficult to trust the data obtained from the ion trap as the 
complexity of assigning fragments ions to two different peptides with different 
charge states increases the number of false positive matches.  
 
Overall, utilising a high/high strategy whereby the Orbitrap detector was used 
at both MS1/MS2 level, yielded the best results. In total, the average number 
of MS2 spectra acquired using the Orbitrap detector for a general digest (both 
treated and untreated samples) were ~600, with 50% of them successfully 
identified as Kif15 peptides. For a BS3 cross-linked sample, ~4% of MS2 
spectra were assigned to a cross-linked peptide and ~12% were assigned to 
a monolinked peptide. As for the Ion trap, an average of ~900 MS2 spectra 
were identified with 0.6% of these identified as cross-linked peptides.  
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Figure 3.9C: Calculated error window for the fragment ions 
detected using the Obritrap and Ion trap. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iontrap
Orbitrap
C
Figure 3.9C:  Calculated Error rate from fragment ions detected using the 
Orbitrap from figure 3.9A in blue, and the ion trap from figure 3.9B in 
gr en   
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3.4 Differential Fragmentation modes for cross-linked 
peptides  
 
3.4.1 Effect of HCD and ETD on fragmentation of cross-linked peptides 
 
The Orbitrap Tribrid Fusion has the ability to perform three modes of 
fragmentation; CID, HCD and ETD fragmentation. For XL-MS, HCD 
fragmentation is often the most used fragmentation technique, as it allows the 
detection of the lowest 1/3 m/z masses which is absent from the data collected 
with the ion trap. This additional fragmentation data is important in allowing 
unambiguous identification of cross-linked peptide.  To systematically assess 
and compare the different fragmentation modes of the Orbitrap Fusion, HCD 
and ETD were tested on the sample cross-linked and digested sample, with 3 
individual replicates. HCD is a beam-type CID fragmentation mode, essentially 
using a higher collision-induced dissociation to produce b and y ions. ETD 
fragmentation is more often been used to study post-translational 
modifications (Mikesh et al., 2006) as it can acquire good sequence coverage 
whilst keeping the modification intact. It has also been shown that ETD 
fragmentation works better for precursor ions of a higher charge state (Kim et 
al., 2012). As we expect to see more highly charged precursor ions for cross-
linked peptides (Chen et al., 2010), it seemed like a good choice to test this 
fragmentation mode along with HCD. Also, HCD and ETD generated different 
ion types; b and y-ions for HCD and c and z-ions for ETD. 
 
Presented below in figure 3.10A and 3.10b are the spectra for the cross-linked 
peptides 884NLQNFKK890 and 916LSLQFEEDK924 (K1513) fragmented with HCD 
and ETD, respectively. As expected, we see a continuous y ion series for the 
alpha peptide in the HCD spectra. Since the cross-link site is located at the c-
terminus of the alpha peptide, each of these y ions, confirms the presence of 
the cross-linker and the second peptide attached. We also see a nice b ion 
series for the alpha peptide to reaffirm the identification of this peptide is 
correct. As for the beta peptide, we see fragmentation to help identify the 
peptide, although not as nice an ion series as seen in the alpha peptide. This 
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is not as surprising as the shorter peptide tends to fragment less than the 
longer peptide in the cross-link. For the ETD spectra, again we see a nice 
fragmentation ion series for the alpha peptide, with continuous z ions detected. 
We also see the presence of c ions to increase confidence in the assignment 
of the alpha peptide. The beta peptide also has less ETD fragments than the 
alpha peptide. 
 
Although presented here is a nice example of the same cross-linked peptide 
identified with both ETD and HCD, it is worth noting that ETD did not work very 
well for all the cross-links. We have only been able to identify 2/22 cross-links 
using ETD fragmentation. The reason ETD did not work very well is not clear, 
however given that the cross-links are mainly a charge state of 3+, this may 
be the reason for the lack of successful identification using ETD as this 
fragmentation mode prefers precursor ions of a higher charge state (4+ or 
higher).  
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3.4.2 Optimisation of collision energy for HCD fragmented cross-linked 
peptides 
 
In order to have a good identification of cross-linked peptides, good 
fragmentation must be achieved for both of the peptides involved in the cross-
linking. Cross-linked peptides identification can also be affected by the 
collision energy employed. There should be enough collision energy applied 
to allow for identification of b and y ion series. However, too much 
fragmentation energy can often result in over-fragmentation, thus rendering 
the spectra unhelpful in identifying cross-linked peptides.  
 
For the HCD fragmentation, collision energy ranging from 25-37% was tested. 
It was noted that there is not a single collision energy that works for all cross-
linked peptides, however, using a lower-range collision energy from 25-30% 
worked much better for the identification of cross-linked peptides. It also gave 
more reliable scoring value from the Stavrox software. Presented in table 3.2 
is a summary of out of 22 cross-links, the number of cross-linked peptides 
identified in Stavrox using different HCD fragmentation collision energies. 
 
Collision Energy Number of cross-links identified 
25%  21 
30%  22 
37%  13 
 
Table 3.2: Cross-linked peptides identified in Stavrox using different 
collision energies. 
 
As an example, presented below in figure 3.11 is the fragmentation spectra 
for the cross-linked peptides 884NLQNFKK890 and 916LSLQFEEDK924 (K1513) 
fragmented using 3 collision energies; 25%, 30%, 37%. From the spectra it is 
very clear that the 37% collision energy is not a good choice of fragmentation 
energy as it over-fragments all the higher m/z fragments that could be used to 
identify the cross-linked peptides. As a result, the spectra is now dominated 
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by smaller m/z fragments, which may be useful in confirming the presence of 
a smaller portion of a single peptide, but not enough to confirm the presence 
of the second cross-linked peptide. In fact, Stavrox software was unable to 
assign this spectrum to any cross-linked peptide candidate, as the over-
fragmentation renders it useless in identifying what peptides are involved in 
the cross-link. 
 
Fragmentation using 25% and 30% gave reliable spectra that could be used 
to identify the cross-linked peptides. Both spectra also gave good Stavrox 
scores of 194 and 177, respectively.  
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3.5 Software analysis and confidence filtering of cross-links 
 
3.5.1 Stable isotope-labelling for cross-linking  
 
Isotope labelling is another way in which cross-linking can be validated. This 
method can serve as an internal control to validate whether the presence of a 
cross-linked peptide is a true cross-link or not. With the isotope labelling, the 
standard BS3 cross-linker is mixed in a 1:1 ratio with a deuterated form of the 
BS3 cross-linker. Both the undeuterated and deuterated form of BS3 
theoretically have an equal chance of forming a cross-link, thus the presence 
of both cross-links can unambiguously confirm the presence of the cross-link. 
 
As previously been reported, the deuterated BS3 molecule, in particular the 
BS3 d12 molecule, can have an effect on the retention time of the cross-linked 
peptide (Fischer et al., 2013). To test the stable isotopes, the Kif15 protein 
was cross-linked with both BS3 d0/d4 and BS3 d0/d12 mixed in a 1:1 ratio. To 
look at the effect of the deuterated molecules on the retention time of the 
precursor ion, the data was analysed for the BS3 d0/d12 dataset as the d12 
deuteration will have the biggest effect on retention time.  
 
Presented below in figure 3.12 shows the retention time difference of BS3 d0 
and d12 for 10 cross-linked peptides. It is clear that the BS3 d12 molecule 
does not significantly cause a shift in the elution profile of the cross-linked 
peptides. This suggests that both the BS3 d12 and the BS3 d4 molecules can 
be mixed in a 1:1 ratio with the lighter BS3 molecule without a significant effect 
on the retention time of the cross-linked peptides.  
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Figure 3.12: The effect of BS3 d12 labelling on the retention time 
difference between BS3 d0 labelling and d12 labelling. 
 
 
Presented in figure 3.13 is an example of a cross-linked peptide identified with 
BS3 undeuterated molecule (red spectra on top) and BS3 d12 molecule (green 
spectra on bottom). From the two spectra below we should see some fragment 
ion peaks that are the same mass (orange fragments) and some shifting mass 
peaks (blue fragments). Of particular interest is the y ion series seen for the 
alpha peptide. These fragments should shift according to the m/z of the peaks. 
Since these fragments are mainly 1+ ions, the corresponding fragments on 
the heavy spectra should be shifting by 12 da.  
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However, isotope labelling is not error-proof as it does not consistently 
produce the mass shifted cross-linked peptides. It was found that isotope 
labelling only worked for a small number of the validated cross-linked peptides. 
Of the 22 monomeric cross-linked peptides identified, only 2 were also 
identified using stable isotope labelled BS3 cross-linker. Even some of the 
cross-linked peptides validated through HCD and ETD fragmentation ions, 
were not matched to an isotope labelled precursor ion. We were concerned 
about these ‘missing’ isotope pairs and wondered if the identification by 
Stavrox was confounding the analysis, especially as the numbers of MS2 
spectra were very high (~600). Therefore, we developed a python script to 
help reduce the numbers of MS2 presented to Stavrox and to determine if 
isotope pairs could be identified. 
 
To help maximise the number of cross-linked peptide pairs recovered, an in-
house developed python script was used, which is an extension of a previously 
developed software by the Jones lab (Wilhelm and Jones, 2014) and similar 
to another software called Modificomb, which is used to study mass shifts 
associated with post-translational modifications (Savitski et al., 2006). The 
python script looks for precursor mass ion pairs related by a specific mass 
shift (such as 12) and then tests the fragment ions to see if the fragment ions 
are related by looking for masses that stay the same (like the orange ions 
annotated in figure 3.13) and masses that move by 12 Da (like the blue ions 
annotated in figure 3.13) enabled to search a large dataset to match heavy 
and light precursor ions relative to their charge state. A threshold window can 
also be adjusted for the ppm and retention time difference. The output file is a 
much smaller file and can be used to input into Stavrox to identify the cross-
linked peptides.  The python script yielded much better results as seen in 
figure 3.14. The number of cross-linked peptide pairs identified with the python 
script are greater than those seen with the Stavrox software alone.  
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Figure 3.14: Venn diagram representing the isotope-labelled cross-
linked pairs found using the standard Stavrox software and the in-house 
python script. The venn diagrams show how many BS3-d4 and BS3-d12 
pairs can be found for a list of 22 cross-linked peptides. 
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3.5.2 Missed cleavages and differential charge states for cross-linked peptides  
 
Trypsin cleavage occurs after lysine and arginine residues. Due to lysine 
residues being a candidate for cross-linking, and that trypsin is very sensitive 
to steric change, the number of missed cleavages is expected to increase for 
when database searching is done for cross-linked peptides. Missed cleavages 
in tryptic peptides is not uncommon. In fact, if a cross-linked peptide can be 
found in different forms, with a missed cleavage and without missed 
cleavages, these give rise to two independent fragmentation spectra with ions 
that can be used to verify the same cross-link. 
 
Presented below in figure 3.15 is an example of a cross-link peptide found with 
a missed cleavage in the alpha peptide (top red spectra) and one without the 
missed cleavage in the alpha peptide (bottom green spectra). Annotated in 
orange are the fragmentation ions that should be present in both spectra, 
whereas those fragments in light blue are those that differ between the two 
spectra. A nice y ion series is identified in both spectra to confirm the identity 
of the presence of the alpha peptide and the corresponding beta peptide 
cross-linked.  
 
Another useful indicator of a true cross-link is to find the same cross-linked 
peptide in different charge states. If the precursor ion for a cross-linked peptide 
can be identified at different charge state, this will produce different MS2 
fragmentation spectra that can be used to independently verify the presence 
of the cross-linked peptide. 
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3.5.3 Quantification using MaxQuant 
 
Maxquant is one of the leading proteomics tools for quantitation (Cox and 
Mann, 2008). Although mostly used for SILAC experiments, the software has 
been expanded to include label-free quantitation (Cox et al., 2014). For any 
given cross-link, the linear peptides of a cross-link should be in a higher 
abundance in the control sample and lower in the cross-linked sample (Figure 
3.17). As such, this can be used as a simplified method to account for a 
change in the abundance of linear peptides between untreated and treated 
samples. In chapter 4, we will also use this quantitation method to help assign 
cross-linked peptides to be dimeric or tetrameric.  
 
 
 
 
 
Figure 3.17: Quantitation of cross-linked peptide K1513.  
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3.6 Kif15 monomeric cross-links summary 
 
To standardize the cross-linking workflow, Kif15 monomeric cross-links have 
been used as an example to demonstrate the different optimization steps 
involved. Presented in figure 3.18 is the schematic organization of Kif15 
monomer. The N-terminal motor domain is followed by several coiled-coil 
domains and a final leucine zipper domain. The numbers presented 
correspond to the list of cross-links presented in table 3.3. Given that Kif15 
does not physiologically function as a monomer, most of these cross-links may 
not be relevant for the understanding of the function of this motor in cells. 
Presented in table 3.3 is also other evidence to increase confidence in the 
presence of the cross-links, such as the presence of the cross-linker in several 
charge states and different cleavage states.  
 
 
 
Figure 3.18: Schematic of the kif15 monomeric cross-links identified. The 
N-terminal motor domain is followed by 4 coiled-coil domains and a final 
leucine-zipper domain. The numbers on the cross-links correspond to the 
cross-links numbers presented in table 3.3.   
Monomeric intra-molecular crosslinks 
K151
K154
K157
K158
K159
K1510
K1513
K1516
K1517
K1518
K1520
K1521
K1522
K1523
K155
K152
K153
K156
K1511
K1512 K1514K1515
376 581 644 706 807 825 1034 1070 1231 1294 1388
Motor domain (19-375 aa)
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3.6 Conclusion 
 
The aim of this chapter was to develop a standardized cross-linking mass 
spectrometry workflow. This involved optimization of the individual steps 
involved in cross-linking mass spectrometry (see figure 3.6) as well as 
developing a software analysis pipeline. 
 
We have successfully been able to optimize the individual steps involved in 
cross-linking mass spectrometry (figure 3.19). Cross-linking using BS3 is a 
good option as the fragmentation chemistry of this cross-linker is well 
understood and the reactive residues of this cross-linker (lysine, serine, 
threonine and tyrosine) are abundant amino acids in proteins. To build a 
constraint map and understand the topology of a protein/protein complex of 
interest, we repeated the cross-linking experiments using a cross-linker with a 
shorter functional distance such as EDC. It was found that cross-linking using 
isotope-labelled BS3 did not produce consistent results, thus this step was 
omitted from the final cross-linking protocol. Depending on the molecular mass 
of the protein of interest the cross-linked sample is separated on a gel (less 
than ~400 kDa) and digested or just cross-linked in solution (any molecular 
weight) and digested in-solution. For a standard gel digest, Trypsin is the 
protease of choice. For an in-solution digest, a combination of Trypsin/Lys-C 
works best as the Lys-C is also able to cleave c-terminal of lysine residues, 
but works better at getting inside tightly folded proteins and digesting less 
accessible areas, which are often missed by the Trypsin. Analysing the 
precursor ions and fragmentation ions using the Orbitrap provides the 
resolution desirable to unambiguously identify the cross-linked peptide. With 
regards to the fragmentation mode, HCD is the best option, and the use of a 
lower collision energy (25-30%) gives the best fragmentation distribution 
required for successful identification of cross-linked peptide. To analyse the 
cross-linked peptides, a combination of Stavrox and MaxQuant seems to yield 
the best results. Stavrox can be used to identify the cross-links, and the 
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MaxQuant software can be used to provide some quantitative data to inform 
the confidence of the cross-linked peptide identified.  
 
 
 
Figure 3.19: Optimised Cross-linking mass spectrometry workflow.  
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Chapter 4: Structural Assembly of Tetrameric 
Kif15 and its Interaction with Tpx2 Revealed by 
Cross-linking Mass Spectrometry 
 
4.1. Introduction 
 
Kinesin 12, Kif15 is a Kinesin that plays an important role in bipolar spindle 
assembly and maintenance (Tanenbaum et al., 2009, Vanneste et al., 2009). 
It consists of 1388 amino acids, with the protein organizing into a tetramer at 
physiological conditions but dissociates into a dimer at higher ionic conditions 
(Drechsler et al., 2014, Mann et al., 2017).  However, another group reports 
Kif15 functions as a dimer (Sturgill et al., 2014). Like many kinesins, Kif15 is 
thought to be auto-inhibited by the back-folding of the carboxy-terminal tail 
interacting with the motor head, thus prohibiting the accessibility of the motor 
domain from binding to the microtubules. Along with Eg5, Kif15 is a second 
tetrameric kinesin which mediates bipolar spindle assembly and maintenance, 
however, unlike Eg5, the structural organization of Kif15 is not well studied. 
Also, the mechanism by which Kif15 auto-inhibits is relatively unknown.  
 
The localisation of Kif15 to the spindle is mediated through the binding of the 
MAP Tpx2. Localisation of kif15 to the spindle requires the C-terminal leucine 
zipper of the motor (Wittmann et al., 2000). Tpx2 C-terminal domain is required 
to localise Kif15 to the spindle (Mann et al., 2017) and the full-length protein 
also inhibits Kif15 motility in vitro (Drechsler et al., 2014; Mann et al., 2017). 
The molecular mechanism by which Tpx2 inhibits Kif15 motility remains 
unclear.  It has been shown that Kif15 cannot bind directly to Tpx2 in the 
absence of microtubules (Wittmann et al., 2000). However, more recent work 
has shown that using ~30-fold excess of Tpx2 dimers (2.5 µM Tpx2 and 80 
nM Kif15) enables complex formation with Kif15 in the absence of 
microtubules, with an enhanced affinity in the presence of microtubules 
(Drechsler et al., 2014). 
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Targeting motor proteins involved in cell division, such as Eg5 and CENP-E, 
have become attractive options for cancer therapies. However, cancer cells 
are developing drug resistance to current Eg-5 inhibitors due to the 
compensatory role of Kif15 in bipolar spindle assembly (Ma et al., 2014). This 
suggests the best way forward for cancer drugs inhibiting bipolar spindle 
assembly would be to simultaneously target both Eg5 and Kif15. In order for 
this to be achieved, further understanding of the structural organisation and 
the functional role of Kif15 is needed. The aim of this project was to understand 
the structural organization of Kif15 from a monomer, to dimer and into a 
tetramer. Also, we wanted to study the auto-inhibited conformation of Kif15 
and which regions of the protein is involved in stabilizing this conformation. 
After understanding the structural assembly of Kif15, this was extended to 
understand the binding interface between Kif15 and Tpx2 and how the 
presence of microtubules may affect this interaction.  
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4.2. Cross-linking/MS analysis of full-length Kif15 
 
 
4.2.1 Cross-linking/MS analysis for Monomeric and Dimeric Kif15 
 
Human Kif15 full length protein containing an amino-terminal polyhistidine tag 
was expressed in SF9 insect cells and purified using a two-step method 
consisting of anion exchange chromatography using a sepharose column, and 
metal affinity chromatography column using a TALON column as reported in 
Drechsler et al., 2014 (Figure 4.1A). Overall, this method enabled the 
purification of 6His-Kif15 to homogeneity, with the protein concentration 
calculated at 2 µM (Figure 4.1B). The protein migrated with expected 
molecular mass of ~165 kDa. The binding to the SP column enables the 
removal of impurities in the sample, as seen in the SP flow-through. Further 
contaminants are removed by binding the lysate to the TALON beads, as seen 
in the TALON flow-through lanes. 
 
The band corresponding to Kif15 was excised from the gel, alkylated, reduced 
and digested using trypsin. To validate the purity of the protein sample used, 
the data obtained from the mass spectrometer was analysed using Mascot. 
This is a commonly used protein identification software (see chapter 3). To 
analyse the data, the Spodoptera frugiperda (SF9) database was searched as 
a background database to identify any other proteins expressed and purified 
with my protein. Also, the human database was used to identify the 
recombinantly expressed Kif15. The average protein coverage for Kif15 was 
~ 75% (Figure 4.1Ci), with little contamination from keratin and ubiquitin in the 
samples (Figure 4.1Cii). This indicates the high purity of the Kif15 protein 
which will be used for subsequent cross-linking experiments. This is essential 
as contaminations in the sample can have a significant effect on the analysis 
of cross-linked peptide analysis.  
 
Post-translational modifications of proteins can also have an effect on the 
conformation adopted by proteins. As such, it is important to identify any 
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modifications associated with the purified Kif15. A single phosphorylation site 
was identified (Figure 4.1D). This phosphorylation site is a previously 
described CDK1 phosphorylation site (Zhou et al., 2013). Multiple formylation 
sites have also been identified, in the motor domain of Kif15 and the neck 
region. Lysine formylation is a common feature of proteins involved in binding 
and regulating chromosome function (Wisniewski et al., 2008). 
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Figure 4.1: Purification and identification of Kif15. A; Schematic to 
illustrate the two step purification of 6His-Kif15. First the SF9 cells are lysed 
and the lysate containing the poly-histidine tagged Kif15 are bound to a SP 
column, which is an ion exchange column, then the sample is bound to TALON 
beads, a Cobalt metal affinity column. B; Coomassie gel to show the 
purification of 6His-Kif15. The flow-through samples from the SP and TALON 
columns show the impurities removed from the sample before Kif15 was 
eluted from the TALON column. Kif15 was eluted as 300 µl aliquots, which 
were used for subsequent cross-linking experiments. Ci; Identification of Kif15 
using Mass Spectometry. Presented in this figure is the sequence coverage 
obtained for Kif15 (~80%), whereby the yellow regions are the unmodified 
peptides identified for Kif15 and the green regions are modifications 
associated with Kif15, such as methionine oxidation or cysteine alkylation 
which are introduced during the digeston protocol. Cii; Proteins identified from 
the extracted gel slice. As seen in this figure, Kif15 is the predominant protein 
identified, with a little contamination from Keratin and Ubiquitin. D; Post-
translational modifications identified in Kif15. 
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To understand the structural assembly of Kif15 into a tetramer, the 
organisation of the protein into a monomer and a dimer must first be studied. 
To do this, the BS3 cross-linker was titrated against Kif15 to obtain a 
monomeric and dimeric Kif15 species. This was calculated as the molecular 
mass of the Kif15 protein expected as a monomeric (165 kDa) and dimeric 
species (330 kDa) (Figure 4.2B). Presented in figure 4.2A is a coomassie gel 
of the titration experiments done for Kif15. As seen on the SDS-PAGE gel, the 
titration of BS3 enables the formation of cross-linked monomeric Kif15 
species, which migrates around 160 kDa. The fuzziness of the protein band 
indicates the presence of the BS3 cross-linker. As a control, untreated Kif15 
protein was also run on the SDS-PAGE, which also runs at ~165 kDa as 
expected. Also, for a higher concentration of BS3, the monomeric species are 
converted into a dimer as indicated by the protein band which appears at ~330 
kDa.  
 
To analyse the monomeric cross-linked species, the band from lane 2 was 
excised, as this sample shows that the majority of the molecules are 
monomeric. The monomeric data is presented in chapter 3. To analyse the 
dimeric species, the band from lane 4 was excised as this represents a state 
where all the molecules are in a dimeric state. The untreated protein band 
from lane 1 was also excised and used as a control. After the gel bands were 
reduced and alkylated, the protein was digested using trypsin and analysed 
using mass spectrometry.  The Stavrox software was used for the analysis of 
the cross-linked peptides. The software generated a list of theoretical cross-
linked peptide candidates, based on an in silico digestion of Kif15, with lysine, 
serine and threonine residues as candidate reactive groups for BS3 cross-
linking. Cysteine alkylation was set as a constant modification and methionine 
oxidation was set as a variable modification. The data was independently 
analysed for Kif15 monomer and the Kif15 dimer data. 
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Figure 4.2: Monomeric and dimeric cross-linking of Kif15. A; Coomassie 
gel showing titration experiments of BS3 cross-linker against Kif15, to obtain 
monomeric and dimeric species on the gel. B; Molecular masses associated 
with Kif15 monomer and dimer species.  
 
Analysing the dimeric Kif15 species, lead to the identification of two types of 
cross-links; intra-molecular cross-links and inter-molecular cross-links. In 
figure 4.3A is a schematic to illustrate the cross-links identified for the dimeric 
Kif15. The dotted green lines indicate the intra-molecular cross-links identified 
for the dimer, which are 11 in total. As can be seen from table 4.2, many of 
these intra-molecular cross-links are long-distance cross-links, which indicate 
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the protein adopts a folded conformation as a dimer. For example, K155, 
cross-links Lys-549 in the peptide 547LEK549 to Lys-1305 in the peptide 
1301AFQEK1305. This is an example of a long-distance cross-link from the 
unstructured region following the motor domain, to the leucine-zipper tail of 
Kif15, which indicates that the amino-terminal is folded and interacts with the 
carboxy-terminal end of the protein. Also, 4 inter-molecular dimeric cross-links 
were identified for Kif15, as indicated by the solid green lines between the two 
monomeric species (Figure 4.3A). These cross-links were mainly identified in 
the two middle coiled-coil regions of the protein (CC2 and CC3). With regards 
to the stagger of the inter-molecular cross-linked peptides identified for both 
the dimer and tetramer, there does not appear to be an obvious correlation to 
the length of the cross-linker. There is not a consistent number of amino acids 
difference between the cross-linked peptides. Similar conclusion was reached 
by Soares et al., after experiments were conducted to study the dimeric and 
tetrameric organisation of the mitotic proteins NDE1 and NDEL1(Soares et al., 
2012). The mass spectra for the dimeric inter-molecular cross-links are 
presented in figure 4.3B-E. As seen for all these spectra, good fragmentation 
for the cross-linked peptides is achieved, which helps to increase the 
confidence in these cross-linked peptides. Also, presented in table 4.1 is a 
summary of additional evidence gathered to increase the confidence of these 
cross-links.  
 
 
 
 
 
 
 
 
 
 
 
	 94	
 
Figure 4.3: Dimeric organisation of Kif15. A; Structural organisation of 
Kif15, whereby the dotted green lines represent the intramolecular dimeric 
cross-links of Kif15, and the solid green lines are the inter-molecular dimeric 
cross-links seen for the dimeric Kif15 molecule. It is assumed that the 
intramolecular dimeric cross-links are specific for a single chain, whereas the 
inter-molecular dimer cross-links connects both chains. B; Cross-linking 
spectra for dimeric cross-link 1 (dK151). For the schematic fragmentation ions, 
the blue colour indicates the b-ions and the red indicates the y-ions. C; Cross-
linking spectra for dimeric cross-link 1 (dK152). D; Cross-linking spectra for 
dimeric cross-link 1 (dK153). E; Cross-linking spectra for dimeric cross-link 1 
(dK152). F; MaxQuant quantification of the precursor ion of inter-molecular 
dimeric cross-linked peptides.   
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To assess the structural organisation of Kif15, Stavrox was used to compare 
the presence and absence of cross-links between different oligomerization 
states. However, a more accurate and quantitative approach is required. To 
do this, the label-free quantitation (LFQ) module of MaxQuant was used. The 
LFQ module calculates the integrated peak area of the precursor ion and 
based on a retention time window and ppm error window, can compare 
different mass spectrometry output files to quantify the presence and absence 
of a precursor ion of interest (Cox et al., 2014). Peptide detection (“flyability”) 
is dependent on chemical properties of the peptide, which affects its ionization, 
thus no direct comparison can be made between their ion intensities. 
However, the intensity of the same precursor ion can be compared across 
different samples. As seen in figure 4.3F, the four dimeric cross-links identified 
are quantified. As seen for all these dimeric cross-links, there is only a little 
background signal (dK151 and dK152) or none (dK153 and dK154) seen in the 
monomeric sample. The data was normalised to the top 3 unmodified peptides 
in each sample.  
 
All of the intra-molecular cross-links for dimeric Kif15 were achieved using BS3 
cross-linker.  As this cross-linker has a spacer arm of 11.4 Å, any cross-links 
identified with BS3 can be used to provide information about the proximity of 
residues within the folded state of a protein. To examine shorter distance 
interactions we also used the cross-linker EDC; the EDC cross-linker does not 
add any atoms to the cross-linked species but instead directly attaches a 
carboxylic amino acid to a primary amine, through the formation of an 
intermediate ester group (Rivera-Santiago et al., 2015). This means that any 
cross-links formed using EDC are within a salt-bridge distance. All the inter-
molecular cross-links identified with BS3 were also identified using EDC (table 
4.1). This indicates that these inter-molecular dimeric cross-links are directly 
attached to one another. Interestingly, only the K151 intra-molecular dimeric 
cross-link was identified with EDC (table 4.1). 
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4.2.3 Cross-linking/MS analysis for Tetrameric Kif15 
 
 
As shown by several labs including the McAinsh lab, Kif15 assembles into a 
tetramer (Drechsler et al., 2014, Drechsler and McAinsh, 2016, Mann et al., 
2017). To assess the structural organisation of tetrameric Kif15, cross-linking 
with BS3 and separation on SDS-PAGE gel was tried. However, due to the 
high molecular weight of a tetrameric complex (~760 kDa), it was unable to 
migrate into the gel. Therefore, a NativePAGE gel electrophoresis method was 
tried, whereby proteins of a larger molecular weight can be separated. Seen 
in figure 4.4A is the NativePAGE gel electrophoresis for the cross-linked 
tetrameric Kif15. The expected molecular mass for tetrameric Kif15 is ~760 
kDa and by looking at the gel, a faint band is visible above the 720 kDa marker 
band, indicating there is a cross-linked tetramer present. This gel band was 
excised, reduced, alkylated and digested with trypsin. There appears to be a 
very faint band around the 1048 kDa marker. However, when untreated Kif15 
is run on a Native-PAGE gel, we do not see higher oligomerisation states, 
suggesting this band may be indicative of an artificial oligomer introduced by 
the cross-linking. 
 
Analysing the tetrameric Kif15 band revealed a few things. Firstly, Kif15 does 
indeed form a tetramer, as two distinct inter-molecular tetrameric cross-links 
were identified. As seen in figure 4.4C, the first tetrameric cross-link (tK151) 
occurs between Lys-410 of peptide 409DKK410 and Ser-428 of peptide 
428SEQEK432 in the unstructured region adjacent to the motor domain of kif15. 
The second cross-link (tK152) identified is between Lys-1187 of peptide 
1180LNEDREVK1187 and Thr-1178 of peptide 1171TSLEHLVTK1179 of the fourth 
coiled-coil region (CC4) (Figure 4.4D). This second cross-link was also 
identified using EDC cross-linker, indicating these residues are direct contact 
sites (Figure 4.4E). The positioning of these tetrameric cross-links also 
indicate that Kif15 can form a parallel tetramer. Also, the 11 intra-molecular 
cross-links identified for the dimeric Kif15 were also present for the tetramer. 
This seems to suggest that Kif15 assembles into a tetramer as a dimer of 
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dimers. Due to the diffusive appearance of the NativePAGE gel band, the 
cross-linking experiment was repeat in solution at low salt concentration, 
where the Kif15 protein exists as a tetramer. These experiments yielded 
similar results (data not presented). 
 
 
 
Figure 4.4: Tetrameric organisation of Kif15. A; Native-PAGE gel of cross-
linked Kif15.B; Structural organisation of Kif15, whereby the dotted green lines 
represent the intramolecular dimeric cross-links of Kif15, and the solid green 
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lines are the inter-molecular dimeric cross-links seen for the dimeric Kif15 
molecule. It is assumed that the intramolecular dimeric cross-links are specific 
for a single chain, whereas the inter-molecular dimer cross-links connects both 
chains The red lines represent the tetrameric cross-links identified C; Spectra 
for BS3 tetrameric cross-link 1 (tK151). For the schematic fragmentation ions, 
the blue colour indicates the b-ions and the red indicates the y-ions. D; Cross-
linking spectra for BS3 tetrameric cross-link 2 (tK152). E; EDC spectra for 
tetrameric cross-link 2 (tK152). F; MaxQuant quantification of inter-molecular 
tetrameric cross-linked peptides.    
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4.2.4 Structural Predictions for Kif15 domain architecture 
 
To further confirm the structural organisation of Kif15 into a tetramer, structural 
prediction analysis was done. The software used was LOGICOIL, a software 
that can predict the oligomeric organization of a protein, based on its protein 
sequence (Vincent et al., 2012). The software used the characteristic heptad 
repeat sequence for coiled –coils, to predict the organization of the protein. 
The heptad repeat, consists of the amino acids HPPHPPP, where the “H” 
refers to a hydrophobic residue and the “P” refers to a polar residue. The 
heptad repeat is a known structural motif in coiled –coils, whereby the amino 
acids are labelled from a to g, and the hydrophobic residues tend to occupy 
the a and d positions. The software assigns an oligo-coiled coil likelihood 
based on similarity to a training set of proteins (see table 4.2). 
 
Training Set 
1ECM 
1EUMC 
1GL2a 
1GL2d 
1X03 
1YBZ 
2B9Ba  
2D8E  
2FXM 
2WPQa 
2Z0V 
 
Table 4.2: List of protein identifiers used as a training set for 
assigning oligo-coiled-coil likelihood.  
 
Presented below in figure 4.5 is the structural predictions obtained from the 
LOGICOIL software. As expected, the most likely oligomerization state for 
Kif15 is a tetramer, with the first coiled-coil region being the most likely 
tetramerisation domain and a further 3 coiled-coil domains expected to form a 
parallel dimer. This is consistent with the data obtained from our cross-linking 
mass spectrometry results and the published results from the McAinsh and 
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Wadsworth labs. Also, the predicted conformation of the dimer is parallel, 
which suggest that Kif15 adopts a parallel tetramer conformation, which is also 
consistent with our cross-linking mass spectrometry results.   
 
Figure 4.5: Predicted oligomerization state and domain architecture of 
Kif15. 4 coiled-coil domains are identified, with the first predicted to be 
involved in the tetramerisation of Kif15 and the other three involved in the 
formation of a parallel dimer. The final domain is the leucine zipper. 
 
 
 
 
4.2.5 Preliminary EM Results 
 
 
XL-MS provides a snapshot of real-time dynamic interactions of the molecules 
in solution, therefore the cross-links identified may be sampled from a large 
conformational space. As such, negative-stain EM would be important to 
confirm the data obtained with XL-MS. To provide further evidence for the 
tetrameric organisation of Kif15, preliminary experiments were carried out to 
assess the structural assembly of Kif15 using negative stain EM. Freshly 
purified Kif15 protein was buffer exchanged to 50 mM Sodium Phosphate, 
20mM NaCl buffer to stabilize the tetrameric state of Kif15 in solution. The 
protein was stained with 0.7% and 0.2% Uranyl Acetate and visualized using 
JEOL 2011 with Gatan Ultrascan 4000 CCD used to image and collect data. 
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Figure 4.6: Preliminary Kif15 negative stain EM. The panels in B is the 
same as A, except for the addition of pseudo colours, whereby the motor 
domain is depicted in purple and the tail is blue. Scale bar is 100 nm.  
 
As seen in figure 4.6 is the images acquired from the EM trials. Figure 4.6Ai, 
which looks slightly more compact than the other images, is acquired using 2 
% uranyl acetate staining. 4.6Aii and 4.6Aiii was obtained using 0.7 % uranyl 
acetate. As is clear from the figures, Kif15 seems to form a parallel tetramer 
organisation. The motor domains appear as a large mass on one end, with an 
extended tail. It appears that for these images that Kif15 is adopting an 
extended conformation. Given that the extended Kif15 molecule is ~130 nm 
long, this is consistent with the data presented here. However, from the EM 
data collected, we also see globular folded conformations which is indicative 
of the auto-inhibited conformation of Kif15 (data not presented), but the 
staining protocol needs to be further optimised to make it easier to visualise. 
Nevertheless, these pilot data are consistent with the XL-MS data and the 
model that Kif15 forms a parallel tetramer. 
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4.3. Cross-linking/MS Analysis of Kif15 1-1293  
 
4.3.1 Cross-linking/MS analysis for Kif15 1-1293 
 
As with many other kinesins, Kif15 activity is modulated by auto-inhibition of 
its C-terminal tail, specifically by the leucine zipper of Kif15 (Sturgill et al., 
2014; McHugh et al., 2017). From the previous data presented, the folded 
state of Kif15 was confirmed (Figure 4.3A and figure 4.4B) as many long range 
cross-links were identified.  
 
One prediction of this auto-inhibited conformation would be that the deletion 
of the leucine-zipper would eliminate the long-distance cross-links identified 
for the Kif15 molecule. To confirm that these extended cross-links were 
specific to the full-length Kif15, the truncated protein lacking the last 93 amino 
acids was expressed and purified. The cross-linking experiments were carried 
out as previously described; the truncated protein was titrated against BS3 to 
form the monomeric species and dimeric species on a SDS-PAGE gel (figure 
4.7B), which were excised, alkylated, reduced and digested with trypsin. For 
the tetrameric species, the cross-linking was done in-solution. To confirm that 
the cross-linked Kif15 protein is truncated, a basic mascot search was done 
to show the absence of the C-terminal end of Kif15, as seen in figure 4.7A. 
The sequence coverage shows that peptides have been identified for all the 
regions, except for the C-terminal end. 
 
The cross-linked peptides for Kif15 1-1293 were analysed in the exact same 
way as the full-length protein. As seen in figure 4.7D, there is a striking 
difference in the conformation of the truncated Kif15, compared to the full-
length protein. The Kif15 1-1293 protein adopts an elongated conformation, 
which does not seem to form any of the long-distance cross-links seen in the 
full-length molecule, such as K151, K155 and K157. An example quantification 
showing the absence of K157 in the truncated molecule is shown in figure 4.7F. 
This is consistent with the literature, as it has been shown that this Kif15 
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truncation is able to alleviate the auto-inhibited conformation of Kif15 and 
restore motility on microtubules (McHugh et al., 2017).  Only 3 intra-molecular 
cross-linked peptides found in the full-length Kif15 molecule were identified in 
the truncated protein (K1511, K1513 and K1520). Instead, we see new intra-
molecular cross-links appear, which are in much closer distance to each other. 
These new cross-links are identified in regions which are now accessible to 
cross-linking due to the unfolded state of the protein.  However, the dimeric 
and tetrameric organization of Kif15 is still the same as the full-length protein, 
suggesting that the truncation does not interfere with the structural 
organization of Kif15 into a tetramer. An example quantification of an inter-
molecular dimeric cross-link (dk151) is presented in figure 4.7F to show the 
equal abundance of this cross-link between the truncated and the full-length 
Kif15 molecule. Cross-links identified for Kif15 1-1293 are summarised in table 
4.3. 
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Figure 4.7: Cross-linking of Kif15 1-293. A; Mass spectrometry analysis of 
full-length Kif15 and Kif15 1-1293 to confirm the truncation of the leucine 
zipper. B; Kif15 1-1293 cross-linking and separation of the monomeric and 
dimeric species on SDS-PAGE gel. C; Predicted and observed masses for 
Kif15 monomeric and dimeric masses separated on SDS-PAGE gel. D; 
Structural organisation of tetrameric Kif15 1-1293. Dotted green lines indicate 
the intra-molecular dimeric cross-links, and muK15 refers to the inter-molecular 
cross-links seen for the Kif15 1-1293 mutant. The solid green lines indicate 
the inter-molecular dimeric cross-links. The red lines indicate the tetrameric 
cross-links. E; MaxQuant quantification of intramolecular cross-link (K157) and 
inter-molecular dimeric (dK151). 
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4.4. Cross-linking/MS Analysis of Tpx2 
 
4.4.1 Tpx2 oligomerisation state 
 
Tpx2 is an important protein involved in microtubule nucleation and 
localisation of different proteins to the mitotic spindle (Groen et al., 2004). 
However, not much progress has been done to biochemically characterise the 
assembly of this protein into its oligomerisation state. Roostalu et al., 2016, 
reported that Tpx2 appears to be monomeric under the purification conditions 
they used, which was done under high ionic strength conditions (300 mM KCl). 
To study the oligomerisation state of this protein, 6His-Tpx2 was expressed 
and purified as specified in Drechsler et al., 2014. The protein was eluted in a 
buffer at physiological ionic strength (75 mM NaCl) and the purified protein, 
which runs as expected at ~100 kDa, is presented in figure 4.8A.  
 
To characterise the oligomerisation state of Tpx2, several experiments were 
carried out. Firstly, a NativePAGE gel electrophoresis was performed. As seen 
in figure 4.8B, the Tpx2 bands appears around the 242 kDa marker band, 
which indicates that the protein is dimeric under physiological ionic conditions. 
Also, using an mKate2 tagged construct of Tpx2, TIRF microscopy photo 
bleaching experiments were carried out. The intensity steps are indicative of 
the photo bleaching of single fluorophores and as such, a two-step change in 
intensity indicates the protein is dimeric (figure 4.8C). Structural prediction 
analysis using the software LOGICOIL confirmed that a parallel dimer was the 
likeliest structural conformation adopted by Tpx2 (figure 4.8D). 
 
	111	
 
 
Figure 4.8: Tpx2 oligomerisation state. A; Coomassie gel of purified 6His-
Tpx2. B; Native-PAGE gel of purified Tpx2. C; Photo bleaching steps for 
mKate fluorophores on Tpx2 molecule. D; Structural prediction for Tpx2 
oligomerisaion state. The pink regions indicate the coiled-coil domains which 
are predicted to form a parallel dimer.  
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4.4.2 Cross-linking/MS analysis for Monomeric and Dimeric Tpx2 
 
 
To analyse the organisation of Tpx2 into a dimer, cross-linking mass 
spectrometry experiments were carried out. The BS3 cross-linker 
concentration was titrated against Tpx2 to optimise the concentration for the 
formation of monomeric Tpx2 cross-linked species. For the monomeric cross-
linked species, the sample was loaded on a standard SDS-PAGE gel (figure 
4.9A). The dimeric cross-linked Tpx2 species was run on a Native-PAGE gel 
(figure 4.9D). For the monomer, the band from lane 3 was excised, alkylated, 
reduced and digested with trypsin. The data was analysed as previously 
described in section 4.2.1.  
 
The monomeric cross-links for Tpx2 are shown in Figure 4.9B. In total, 4 cross-
links have been identified, whereby 2 are long distance cross-links and 2 are 
closer to each other. The first long distance cross-link (Tpx21) is between Lys-
701 of peptide 701KEELAR706 and G-501 of peptide 488EDEEEDEPVVIK501. 
The second extended cross-link (Tpx24) is between Lys-128 of 
peptide124LSAQK128 and Lys-443 of peptide 438IQERESK443. In figure 4.7C is 
the Tpx24 cross-linked spectra identified using EDC.  
 
To analyse the dimeric Tpx2 cross-links, the cross-linked sample was isolated 
using NativePAGE gel electrophoresis to maintain the dimeric nature of the 
protein (figure 4.9D). Presented in figure 4.9E is the cross-linked peptides 
identified for the dimeric Tpx2 molecule. As is clear from this diagram, the 
carboxy-terminal end of Tpx2, including the second coiled-coil domain (CC2) 
are important for stabilising the dimeric state of Tpx2 as all of the dimeric 
cross-links are identified in this region. Also, intra-molecular cross-links Tpx21, 
Tpx23 and Tpx24 from the monomer are also seen for the dimer.  
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Figure 4.9: Monomeric and dimeric cross-linking for Tpx2. A; Coomassie 
gel of BS3 titration experiments to optimise monomeric cross-linking of Tpx2. 
B; Monomeric cross-links identified for Tpx2. C; Mass spectra of the Tpx21 
cross-link using EDC. D; Native-PAGE gel for dimeric cross-linked Tpx2. E; 
intra-molecular and inter-molecular dimeric cross-links identified for Tpx2. F; 
Mass spectra for dTpx23. 
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4.5. Cross-linking/MS Analysis of Kif15/Tpx2 Complex  
 
 
4.5.1 Cross-linking/MS analysis for Kif15/Tpx2 complex  
 
 
It is known that Tpx2 and Kif15 can directly bind to each other and Tpx2 is 
required to localise Kif15 to the mitotic spindle. Work from the Wadsworth lab 
has identified the C-terminal end of Tpx2 as important in regulating Kif15 
localisation and function (Mann et al., 2017).  
 
To assess the direct binding between Tpx2 and Kif15, cross-linking mass 
spectrometry experiments were carried out. As previously described, 30-fold 
excess of Tpx2 is required to enable complex formation with Kif15 (Drechsler 
et al., 2017). The cross-linking experiments were done for Kif15 and Tpx2 
using EDC cross-linker in-solution, followed by an in-solution tryptic digest. 
Presented in figure 4.10A is a diagram showing the cross-linking sites 
identified between Kif15 and Tpx2. In total, 3 cross-links were identified 
between Kif15 and Tpx2 (KT1, KT2 and KT3). All of these cross-links localise 
to the fourth coiled-coil domain (CC4) and not the leucine zipper of Kif15. It is 
known that Kif15 binding to Tpx2 in the absence of microtubules is a low 
affinity binding and this binding to the fourth coiled-coil domain may be 
indicative of this. The Tpx2 binding site is mainly the middle region of the 
protein, with one cross-link identified near the N-terminal end. Interestingly, 
the intra-molecular cross-links seen for Kif15 dimer and tetramer are also 
identified in the presence of Tpx2 (green lines). This suggests that Tpx2 is 
able to stabilise the folded conformation of Kif15. Presented in figure 4.10B is 
the spectra for the cross-link KT2. 
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Figure 4.10: Cross-linking of Kif15 and TPX2 in the absence of 
microtubules. A; Cross-links identified between Kif15 and Tpx2 (KT1, KT2, 
KT3). B; Mass spectra for the KT2 cross-link identified between Kif15 and 
Tpx2.  
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4.5.1 Cross-linking/MS analysis for Kif15/Tpx2/MT complex  
 
 
As the binding between Tpx2 and Kif15 is enhanced by the presence of 
microtubules, the next experiment was to probe the interaction between Kif15 
and Tpx2 in the presence of microtubules. Tpx2 and Kif15 were incubated for 
10 minutes with GMP-CPP stabilized microtubules in the presence of AMP-
PNP to enable the kinesin to lock onto the microtubules. The sample was then 
spun at high-speed to remove unbound kinesin and Tpx2 and free tubulin 
subunits. The sample was then cross-linked with EDC for 1 hour and 
quenched for 30 minutes. A standard in-solution digest protocol was then 
followed.  
 
In the presence of microtubules, Kif15 binding to Tpx2 adopts a different 
conformation (figure 4.11A). The leucine zipper of Kif15 forms 3 cross-links 
with the middle region of Tpx2 (MTKT1, MTKT2 and MTKT3). There is one cross-
link from the fourth coiled-coil domain of Kif15 that interacts with Tpx2. This 
shows a significant conformational shift in the binding between tpx2 and Kif15 
between the presence and the absence of microtubules. In the absence of the 
microtubules, the binding is exclusively localized to the fourth coiled-coiled 
(CC4) domain of Kif15, whereas in the presence of microtubules, the binding 
is mainly in the leucine zipper of Kif15. In both cases, Kif15 adopts a folded 
conformation as many long-distance cross-links for Kif15 are found. This 
suggests that Tpx2 binding to Kif15 stabilises the kinesin in its auto-inhibited 
conformation.  
 
A single cross-link between Tpx2 and a-tubulin was identified. This cross-link 
mapped to residue K-336 of the a-tubulin monomer in helix-10, which sits at 
the inter-dimer interface of the microtubule (Nogales et al., 1998). No cross-
links were identified between Kif15 and the microtubules.  
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Figure 4.11: Cross-linking of Kif15 and TPX2 in the presence of 
microtubules. A; Cross-links identified between Kif15 and Tpx2 in the 
presence of microtubules (MTKT1, MTKT2, MTKT3). Highlighted in red in the 
crystal structure of the tubulin heterodimer is the K-336, which forms a cross-
link with Tpx2. In green is the a-tubulin and in cyan is the b-tubulin. Structure 
adapted from Nogales et al., 1998. B; Mass spectra for the KT2 cross-link 
identified between Kif15 and Tpx2.  
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4.6 Conclusion  
 
 
Presented in this chapter is the cross-linking mass spectrometry data to show 
the structural organization of Kif15 from a monomeric state, to a dimer and 
finally a tetramer. Kif15 forms a folded conformation, where long distance 
cross-links are found which extend from the N-terminal end to the C-terminal 
tail (such as K155 and K157). Kif15 also forms distinct inter-molecular dimeric 
cross-links (dK151, dK152, dK153 and dK154) which are mainly localized in the 
second (CC2) and third coiled-coil (CC3) domains, which are predicted to 
stabilize a parallel dimer structure. Two distinct tetrameric cross-links (tK151 
and tK152) were identified, which appears to suggest Kif15 organises into a 
parallel tetramer conformation. One tetrameric interface is near the predicted 
tetramerisation domain and the second cross-link is found in the fourth coiled-
coil (CC4) domain.  
 
This data confirming that Kif15 forms a tetramer is of great importance as it 
helps to clear up a controversial issue in the field regarding the structural 
organization of Kif15 (Hancock et al., 2014). The McAinsh lab and Wadsworth 
lab have both confirmed that Kif15 assembles into a tetrameric conformation 
under physiological conditions, and can fall apart into a dimer at high salt 
concentrations. However, the Ohi lab suggest that Kif15 functions as a dimer, 
under their experimental conditions (HEPES buffer with 300 mM NaCl), which 
has previously been confirmed to destabilize the tetrameric state of Kif15 into 
a dimer (Drechsler et al., 2014).   
 
Also, presented in this chapter is the structural organization of Kif15 1-1293, 
which lacks the C-terminal domain (last 93 amino acids) that is important for 
stabilizing the auto-inhibited conformation of Kif15. As expected, this mutant 
lacks the long-distance cross-links (such as K155 and K157) present in the full-
length protein and therefore adopts a more open conformation. The unfolded 
conformation adopted by Kif15 1-1293 also reveals new cross-links identified 
(such as MUK154, MUK155 and MUK156). The dimeric and tetrameric cross-links 
	123	
are still present, which suggests that the mutant does not interfere with its 
ability to form a tetramer. 
  
Also seen in this chapter is the cross-linking mass spectrometry analysis to 
study the structural organisation of Tpx2 into a dimer. The Surrey lab have 
previously presented data to suggest that Tpx2 is a dimer, under high ionic 
salt concentrations (300 mM KCl). However, from our experiments, it was 
found that Tpx2 organises into a dimer at physiological ionic conditions (75 
mM NaCl).  
 
Tpx2 is a known binding partner of Kif15 which inhibits the motors motility on 
microtubules in-vitro. However, in the absence of microtubules, this binding is 
low affinity. To study the interaction between Tpx2 and Kif15, the cross-linking 
experiments were done in the presence and absence of microtubules. There 
is a striking conformational shift between these experiments; in the absence 
of microtubules, Tpx2 mainly interacts with the fourth coiled-coil domain of 
Kif15 (KT1, KT2 and KT3), whereas in the presence of microtubules, the main 
interaction site is the leucine zipper of Kif15 (MTK152, MTK153, MTK154).  
 
Interestingly, Kif15 adopts the same folded conformation in the presence of 
Tpx2, regardless of the presence or absence of microtubules. This may 
suggest that the mechanism by which Tpx2 inhibits Kif15 motility is through 
the stabilisation of the auto-inhibited conformation of Kif15.  
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Chapter 5: Towards in-vivo analysis of Kif15 
structure and function 
 
5.1 Introduction  
 
Based on the data presented in the previous chapter, we now have an 
improved model of how Kif15 motors are organised into a tetramer in-vitro and 
which interaction sites are important in stabilising the Kif15-Tpx2 complex. 
However, the majority of work to characterise Kif15 function is based on in-
vitro motility assays, therefore, more in-vivo work will be needed to further 
understand how the structural organisation of Kif15 contributes to the function 
of the motor in cells. It is therefore crucial to establish a system to remove 
endogenous Kif15 from cells and then introduce transgenes harbouring 
specific mutations that alter the structural organisation of the KIF15 motor 
and/or its capacity to interact with binding partners (i.e. Tpx2). Previous work 
using genome editing has reported that Kif15 is non-essential in HeLa cells 
(Sturgill et al., 2016) and so we set out to build such a cell line in human retinal 
pigment epithelial cells (hTERT-RPE1). These cells are immortalised with 
telomerase, but have a stable diploid karyotype and are a powerful system to 
dissect the function of Kif15, specifically the mechanism by which it is able to 
drive Eg5-independent bipolar spindle assembly. Presented in this chapter is 
the initial characterisation of the phenotypes observed for RPE1 Kif15 knock-
out clones. 
 
Similarly, all the XL-MS data presented in this thesis was generated by cross-
linking purified proteins and multi-protein complexes in vitro. One caveat of 
this approach is that these interactions are not always indicative of how the 
protein folds or functions in cells. To gain insight into how this protein is folded 
in cells and which protein complexes it can form, a second cross-linker was 
tested. This cleavable, disuccinimidyl sulfoxide (DSSO) cross-linker has been 
optimised for cross-linking proteins on beads after an affinity pull-down 
approach. DSSO cross-linking can not only reveal the structural organisation 
of Kif15 in-vivo, but also show what proteins Kif15 interacts with and their 
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precise interaction sites. Before this cross-linker can be tested on Kif15 
complexes isolated from human cells, initial experiments were carried out on 
purified Kif15 to test the fragmentation chemistry of DSSO. Using this 
approach, the broader protein-protein interaction networks formed by Kif15 in 
vivo will be tractable. 
 
5.2 CRISPR knock-out cell lines for Kif15 
 
To provide further understanding of the role of Kif15 in-vivo, genome editing 
using CRISPR-Cas9 system was used to generate Kif15 knock-out cell lines 
in RPE1 cells that stably express mCherry-alpha-tubulin. Small guide (sg) 
RNAs were designed that targeted the first exon of KIF15; the aim being to 
generate INDELs that would result in premature stop codons and a loss of 
protein expression.  Following transformation with a plasmid expressing both 
the sgRNA and GFP-Cas9, I isolated a population of GFP positive cells. Next, 
by diluting and plating the cells I generated 40 single cell clones and choose 
20 for further analysis by quantitative immunofluorescence. Both Parental 
RPE1 cells and isolated clones were stained with antibodies that recognise 
the carboxy-terminus of the Kif15 protein (Figure 5.1). As expected Kif15 was 
localised to the mitotic spindle microtubules in the parental cells co-localising 
with the mCherry-alpha-Tubulin signal (Fig 5.1A). It is not clear from these 
images that Kif15 is localised at the kinetochores; further staining using 
kinetochore markers such as CREST will be needed to validate this. This 
analysis revealed two distinct localisation phenotypes for the CRISPR clones: 
In the first (1/20 clones screened), we found that Kif15 protein was 
undetectable on the mitotic spindle. This clone is named MC174 and is shown 
in Figure 5.1B. Because our antibodies recognise the carboxy-terminus of the 
protein it is likely that this clone has lost both KIF15 alleles – although this will 
need confirmation by western blotting and genome sequencing. The second 
phenotype named MC175, which was found in 8 of 20 clones also displays a 
loss of Kif15 from the mitotic spindle, however surprisingly the motor is now 
localised at the kinetochores (Fig. 5.1C). These experiments demonstrate how 
we can target the KIF15 locus with the Cas9 system and opens up important 
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new research possibilities to analyse the in-vivo function of Kif15 (See 
discussion for details).  
 
Figure 5.1: Generation of Kif15 knock-out cell lines. A; Parental RPE-
mCherry-tubulin cell arrested at metaphase and stained for Kif15 (green) and 
DAPI (blue) B; Clone MC174 arrested at metaphase and stained for Kif15 and 
DAPI and imaged for a-tubulin (red). C; Clone MC175 arrested at metaphase 
and stained for Kif15 (green) and DAPI (blue) and imaged for a-tubulin (red). 
Scale bar is 10 µm. D; Quantified spindle microtubule localisation of Kif15. 
Quantification of the intensity of the signal at the mitotic spindle was 
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background subtracted and normalised relative to the parental spindle 
intensity. 
 
 
 
5.2 DSSO cross-linking 
 
In recent years, a cleavable disuccinimidyl sulfoxide (DSSO) has been 
developed to provide unambiguous identification of cross-linked peptides. 
DSSO has also been used to study protein-protein interactions in-vivo by 
carrying out the cross-linking on beads. The cross-linker is able to be cleaved 
at two distinct sites by Collision-Induced Dissociation (CID), which produces 
reporter ions which can easily be identified. This fragmentation occurs prior to 
peptide backbone fragmentation, thus can be used as a condition to allow 
fragmentation only after the reporter ions have been identified.  
 
Before testing the DSSO cross-linker on affinity purified protein complexes, 
we first tested this cross-linker on our purified full length Kif15 protein from 
insect cells. In a first experiment,  2 µM Kif15 was cross-linked with 1 mM 
DSSO and digested following the in-solution digest protocol. Presented in 
figure 5.2 is an example of a cross-linked peptide, 1258SK($)IVEEMLK1265 and 
1244NEQEESIK($)ER1251, identified using DSSO. In figure 5.2A is the structure 
of the DSSO cross-linker. As is clear from the diagram, fragmentation can 
occur on either side of the sulfoxide group. Figure 5.2B is the CID 
fragmentation of the DSSO cross-linker backbone. CID fragmentation is used 
to produce enough energy to fragment the cross-linker backbone but not 
fragment the cross-linked peptides. The fragmentation on either side of the C-
S bond generates a pair of peptide fragments for each of the cross-linked 
peptide (a-b). The annotation aA/bs indicates that the fragmentation of the 
DSSO cross-linker has resulted in the a peptide being modified with the alkene 
group, whereas the b peptide is modified with the sulfenic acid group. In total, 
there are four reporter ions associated with DSSO cross-linker fragmentation; 
aA, as, bA, bs. The mass difference between the aA/bA and as/bs fragments is 
32 Da, which is the mass difference between the thiol and alkene groups 
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(Figure 5.2B). Presented in figure 5.2C is the EThcD fragmentation of the 
cross-linked peptides. The Orbitrap fusion instrument allows a combination 
fragmentation using ETD and HCD (EThcD), which has been shown to provide 
the best fragmentation coverage for DSSO cross-linked peptides. The next 
step now would be to affinity purify Kif15 and do the cross-linking on beads to 
identify any protein complexes Kif15 forms in-vivo.  
 
Figure 5.2: DSSO cross-linking of Kif15. A; Structure of DSSO cross-linker. 
B; MS2 fragmentation of DSSO backbone using CID. C; MS2 fragmentation 
of cross-linked peptides using EThcD. 
 
A
B
C
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5.3 Conclusion 
 
In this chapter we have established and developed two key new tools that are 
essential for future work. Firstly, the putative CRISPR Kif15 knock-out cell 
lines provide an exciting opportunity to characterise the role of Kif15 in-vivo. 
However, the clones first need to be sequenced to verify the exact mutation 
which is causing the striking phenotype difference between the CRISPR 
clones. These cell lines can then be used to characterise Kif15 cross-linking 
mutants in-vivo, to study their effects on motor localisation and function. 
Secondly, now that preliminary experiments have confirmed the fragmentation 
chemistry of the DSSO cross-linker, it can now be tested on affinity-purified 
Kif15 to confirm the structural organization of kif15 tetramers in-vivo to confirm 
our structural model and identify any Kif15 protein interaction networks.  
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Chapter 6: Discussion  
 
 
6.1 Discussion 
 
Overall, in this thesis we have successfully been able to develop a cross-
linking mass spectrometry and analysis workflow to study protein topology and 
protein-protein interactions. XL-MS has become a widely popular tool to study 
protein structure in their native state and has been integrated into the workflow 
of other high-resolution structural techniques (Schmidt and Urlaub, 2017). The 
highlight of this work using XL-MS, is that we have been able to elucidate for 
the first time the tetrameric structural assembly of Kif15 and how it interacts 
with its binding partner and regulatory subunit, Tpx2. 
 
It is important however, to note and discuss a number of caveats regarding 
the use of XL-MS. Firstly, the abundance of cross-linked peptides is much 
lower than linear peptides and mono-linked peptides. This makes the data 
analysis more complicated and protein concentrations for cross-linking should 
be balanced to optimise the abundance of cross-linked peptides on one hand 
but also to prevent protein aggregation in the event of excess protein 
concentration. Also, because the cross-linking provides a snapshot of the real-
time dynamic interactions of a protein, cross-links identified may be sampled 
from a large conformational space, thus this needs to be taken into 
consideration when the data is being analysed. i.e. one cannot assume that 
all cross-linking events are associated with a single molecular species. Finally, 
the BS3 cross-linker has been widely used as the cross-linker of choice in this 
field, however given its functional distance of 11.4 Å, cross-linked residues 
identified using this reagent may not indicate direct contact sites, but rather 
provide an idea of residue proximity. 
 
 
	131	
6.1.1 Kif15 organises into a parallel tetramer conformation 
 
To fully understand the function of Kif15 at a cellular level, it is important to 
understand its oligomeric state, which will affect its ability to generate the 
microtubule-based forces required for the establishment and the maintenance 
of the bipolar spindle during mitosis. The dominant motor involved in bipolar 
spindle assembly and maintenance is the Kinesin-5, Eg5. Eg5 has been 
established as a bipolar tetrameric kinesin (Acar et al., 2013, Scholey et al., 
2014), whereby the two sets of motor heads enable the motor to attached to 
anti-parallel microtubules and drive extensile sliding (Kapitein et al., 2005). 
Unlike many other dimeric Kinesins, the rigidity of the coiled-coil domains of 
Eg5 tail, prevents the two sets of motor heads from binding to the same 
microtubule (Scholey et al., 2014). Despite, Kif15 playing a compensatory role 
for Eg5 in the assembly and maintenance of the bipolar spindle, these two 
motors have some significantly different localisations and modes of action. For 
example, Kif15 localisation is enhanced on k-fibres, where the microtubules 
are parallel bundles instead of anti-parallel microtubules (Sturgill et al., 2014). 
Also, Kif15 generates forces, which antagonise those produced by Eg5 
(Sturgill and Ohi, 2013, Vladimirou et al., 2013). Due to the markedly different 
mechanisms of action of these motors, it is crucial to undertake a detailed 
biochemical characterisation of the Kif15 motor and how its quaternary state 
contributes to mitotic spindle function. 
 
There are conflicting views regarding the structural organisation of Kif15 
motors. The first Kif15 protein discovered was the Xenopus homologue, Xklp2, 
which was shown to be homodimeric using hydrodynamic analysis methods 
of the full-length protein (Wittmann et al., 1998). However, the initial 
biochemical analysis of full-length human Kif15 (hKiF15) revealed a 
homotetrameric configuration at physiological ionic strength (~150mM NaCl), 
which was confirmed using a combination of techniques, including Native-
PAGE gel, size-exclusion chromatography combined with multi-angle light 
scattering (SEC-MALS) and photo-bleaching experiments of single-molecules 
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using total internal reflection microscopy (TIRF) (Drechsler et al., 2014). 
However, data published by Ohi and colleagues (Sturgill et al., 2014, 
Reinemann et al., 2017), reported contradictory results; a truncated form of 
hKif15 (lacking amino acids 8-21) appeared as a dimer as evidenced by 
photobleaching experiments and size–exclusion chromatography (Sturgill et 
al., 2014). It is important to note that these experiments were all carried out in 
the presence of 300 mM KCL, which is unanimously agreed to promote the 
formation of a dimeric population. Indeed, Drechsler et al., directly showed 
how increasing salt to 300 mM NaCl converted the protein from 
monodispersed molecule with a sedimentation coefficient ~12S at 
physiological ionic strength (0-150 mM NaCl), into a species that runs at ~8S. 
This is consistent with the SEC-MALS experiments which showed that at 
physiological ionic strength, the majority of Kif15 molecules have a molecular 
weight of 744.4 ± 14.1 kDa which corresponds to the tetramer, with a minor 
dimeric population also detectable (360.1 ± 6.5 kDa). Interestingly, the Xklp2 
purification experiments were originally carried out in the presence of HEPES 
buffer, which has also been shown by Drechsler et al., to stabilise the dimeric 
conformation of the motor. The data in the field are therefore self-consistent 
when salt-dependence is taken into account. These experiments do not of 
course address whether the motor is a dimer or tetramer in vivo. To assess 
the oligomerisation state of hKif15 in-vivo, endogenous Kif15 from human 
mitotic and interphase cell extracts were shown to be largely tetrameric with a 
smaller dimeric population (Drechsler and McAinsh, 2016, Mann et al., 2017). 
Dreschler et al., confirmed these results using the same sedimentation 
experiments used for the recombinant Kif15, and once again, the endogenous 
Kif15 was also shown to be a tetramer with a sedimentation coefficient ~12S 
at physiological ionic strength. Mann et al., went a step further and purified 
endogenous GFP-Kif15 from both interphase and mitotic cell extracts and 
used single molecule imaging to show how Kif15 motors bleached in three 
steps consistent with a tetrameric organisation. These data support a model 
in which hKif15 is likely to be a dimer-of-dimers with assembly into a tetramer 
being salt-sensitive. It is unlikely that Kif15 can further polymerise into higher-
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order oligomers. It has been shown that the Kif15 motor is a highly acrobatic 
motor that can navigate complex microtubule intersections through track-
switching during processive runs (Drechsler et al., 2014). It is plausible to 
imagine that a Kif15 polymer would be inherently less flexible to undergo such 
acrobatic switches. Also, for some functions, such as regulating catastrophe 
events on the microtubule plus-end,  Kif15 motors can cooperate in teams 
consisting up to 11 tetramers (Drechsler and McAinsh, 2016). 
 
Our work provides direct support for this model. First, XL-MS data for the 
dimeric population of Kif15 can be mapped onto predicted structural elements 
in the molecule: There are three predicted coiled-coils (CC2-4) that have a 
preference for a parallel organisation (Figure 4.5). The inter-molecular dimeric 
cross-links for Kif15 were identified in CC3, CC4 and the unstructured region 
connecting these coiled-coils. We suggest that these regions form the 
structural core of the dimeric Kif15. Second, from our XL-MS data, we 
identified two key sites in the molecule that are in close proximity in the 
tetrameric state (TK151 and TK152). The first is positioned in unstructured 
region adjacent to the motor domain while the second is within the fourth coiled 
coil (CC4). We thus envisage that Kif15 organises into a tetramer as a dimer-
of-dimers, whereby at least at least one of the tetrameric cross-links identified 
are stabilised through electrostatic interactions. To understand the  
organisation of the a-helices where these cross-linked residues lie, a helical 
wheel diagram was drawn. As seen from the helical wheel diagram for the 
second tetrameric Kif15 cross-link (TK152), the two cross-link residues are 
present on opposite a-helices, which display an almost perfect charge reversal 
in the amino acids present in these helices. One a-helix is NPPPPN, whereby 
the “N” indicates a non-polar side chain and “P” indicates a polar side chain. 
The opposite strand is PNNPNP. This seems to indicate that the tetrameric 
Kif15 is stabilised through ionic interactions, which can dissociate into a dimer 
in a salt-dependent manner. This is consistent with the data previously 
discussed, showing that tetrameric conformation of Kif15 is indeed ionic 
strength dependent, as physiological ionic strength stabilises the tetrameric 
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conformation of the motor, whereas non-physiological salt concentrations 
dissociates the motor into a dimer (Drechsler and McAinsh, 2016). This mode 
of interaction also suggests that Kif15 tetramers do not form a BASS domain 
like structure as found for the Eg5 tetramer. 
 
 
 
 
 
Figure 6.1: Sequence alignment and helical wheel analysis of the second 
tetrameric cross-link identified (TK152). A; Sequence alignment of the 
cross-linked residues Thr-1178 and Lys-1187 in TK152. B; Helical wheel 
diagram of cross-link TK152. The wheel diagram allows the representation of 
a-helices, specifically the ability to look down the helical axis to see the 
residues which are interacting together. 
 
 
Also, the location of the tetrameric cross-links identified support a model in 
which Kif15 adopts a parallel tetrameric conformation, which is also supported 
by our preliminary EM data. Our data helps to further explain recent 
experiments showing that a change in the microtubule geometry affects the 
A
B
A
B
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velocity differential between Kif15 motor domain pairs required for microtubule 
transport (Drechsler and McAinsh, 2016). The best explanation for why a 
change in microtubule geometry would induce a conformational change which 
selectively impairs the stepping of one motor domain pair would be a parallel 
tetramer conformation; this would enable the coiled-coil tail to provide 
asymmetric structure so that any torsion may affect only one set of motor 
domain pair. This is consistent with data from the symmetric anti-parallel 
tetramer Eg5, which does not show any velocity differential induced by a 
change in microtubule geometry (Kapitein et al., 2005). 
 
6.1.2 Kif15 Leucine Zipper is required to stabilise its auto-inhibited state  
 
Kif15 is thought to regulate its activity through auto-inhibition of its C-terminal 
coil 2 (residues 961–1388) with the motor domain (Sturgill et al., 2014). 
Furthermore, the leucine-zipper (residues 1294-1388), which also is known to 
bind to Tpx2, has been shown to promote the auto-inhibited conformation of 
Kif15, which is a strongly-bound state unlike the autoinhibited conformation of 
Kinesin-1, which is a weakly-bound state (McHugh et al., 2017). To assess the 
molecular mechanism of this auto-inhibited conformation of Kif15, we 
compared the structural assembly of the full-length Kif15 molecule with Kif15 
1-1293. Given that the Kif15 tail (Kif151149–1388) on its own cannot bind 
microtubules, this suggests that the mechanism of auto-inhibition is regulated 
through the back-folding of the motor, which results in blocking the Kif15 motor 
domain (Klejnot et al., 2014). This is consistent with the cross-linking for the 
full-length Kif15 protein, as many long distance cross-links were found, which 
indicates the folded nature of the molecule (figure 6.2). Of particular interest 
was the long-distance cross-link extending from the leucine zipper to the N-
terminal end of the molecule (K155). Interestingly, no cross-links extending 
from the motor domain were identified. This may be due to a limitation of the 
cross-linker not being very amenable to folded globular domains. Consistent 
with this back-folding model and experiments from McHugh et al, depletion of 
the LZ (Kif15 1-1293 molecule) resulted in loss of the long distance cross-links 
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identified in the full-length protein, indicating that it adopts a more extended 
conformation. This extended conformation also reveals regions which are now 
accessible to the cross-linker and forms new short-distance cross-links, such 
as the motor domain, CC3 and CC4. Thus, Kif15 can exist in at least two 
distinct conformational states, one that is inhibitory to motor function. We term 
these as Kif15on and Kif15off. 
 
 
Figure 6.2: Potential structural organisation of Kif15 in active and 
autoinhibited conformations. Each segment is ~40 amino acids. According 
to the XL-MS data for Kif15 full-length, it appears that Kif15 has three main 
folds, consisting of fold 1 (amino acids ~500-800), fold 2 (amino acids ~800-
1100) and fold 3 (amino acids ~1100-tail to 500).  
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Of interest would be to further explore the mechanism by which this auto-
inhibitory is relieved thus promoting the switch from Kif15off to Kif15on. As seen 
with many other Kinesins, such as CENP-E, such auto-inhibition is relieved by 
phosphorylation (Espeut et al., 2008). Aurora A phosphorylation of Kif15 at 
serine 1169 has been shown to be important for the mitotic spindle localisation 
of the motor (van Heesbeen et al., 2017). One hypothesis would be that this 
phosphorylation is required to spatially regulate Kif15 within the mitotic 
spindle, so that it is activated as required (Figure 6.3). During interphase, the 
motor activity is limited, thus it is mainly in an auto-inhibited conformation. 
Aurora A phosphorylation localises the motor to the mitotic spindle, where its 
activity is required for bipolar spindle maintenance, thus it adopts an active 
conformation.  Interestingly, the S-1169 (S49) residue is adjacent to the circled 
K67 residue involved in stabilising the tetrameric structure of the helical wheel 
diagram (Figure 6.1B). It may be that the stabilisation of Kif15 tetramer through 
cross-link TK152 (circled residues in helical wheel) induces a conformation 
which exposes S-1169 for Aurora A phosphorylation and subsequent 
localisation of the motor to the spindle. This would explain why majority of the 
Kif15 motors on the spindle display a tetrameric conformation (Mann et al., 
2017). However, Aurora A is not the only protein shown to be required to 
localise the motor to the spindle, as binding to Tpx2 also re-locates Kif15 to 
the mitotic spindle. It is not clear whether Tpx2 is directly required for targeting 
Kif15 to the mitotic spindle or whether this MAP plays an indirect role through 
activation of the Aurora A kinase. (for further discussion see 6.1.3 Tpx2 
stabilises the Auto-inhibited conformation of Kif15). 
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Figure 6.3: Possible model for Kif15 autoinhibition regulation. In 
interphase cells, where Kif15 activity is limited, the motor is mostly in its 
autoinhibited conformation. Phosphorylation by Aurora A relocates the motor 
to the mitotic spindle, where it unfolds and resumes full motility. 
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Of particular interest is the conformational shift in the binding between Tpx2 
and Kif15 in the presence and absence of microtubules. In the absence of 
microtubules, Tpx2 exclusively binds to/near the fourth coiled-coil (CC4) 
region of Kif15. However, in the presence of microtubules, Tpx2 mainly 
contacts the leucine zipper of Kif15, with one cross-link found to CC4 of Kif15. 
The conformational shift in binding region between Tpx2 and Kif15 is likely 
affinity-driven as in the absence of microtubules, these proteins do not bind 
tightly to one another (Drechsler et al., 2014). It has also been shown that 
Tpx2 is able to inhibit Kif15 in a leucine zipper-independent manner (McHugh 
et al. 2017). This is consistent with the data presented here as in the presence 
of microtubules, in addition to the cross-links to the leucine zipper of Kif15, we 
also identified a cross-link binding to CC4 of Kif15.  
 
Tpx2 also inhibits Eg5 motility through binding to its C-terminal tail. For Kif15, 
the presence of Tpx2 generates a static (higher load-bearing) cross-link 
between the motor and the microtubules (Drechsler et al., 2014). This might 
be useful in stabilising and further bundling the parallel microtubules found in 
the k-fibre. It has been shown that Tpx2 also inhibits Eg5 motility through 
binding to its C-terminal tail (Balchand et al., 2015). It is probable that that the 
presence of Tpx2 also stabilises the antiparallel microtubules, which are 
required for Eg5 motility. Despite the role of Tpx2 in aiding Kif15 binding to the 
microtubules, none of the experiments carried out were able to reveal any 
direct cross-links between the microtubules and Kif15. The reason for this is 
unclear, however the conformation of the microtubule-Kif15 binding sites, may 
not make it amenable for cross-linking. 
 
Our cross-linking data only revealed a single cross-link between Tpx2 and 
MT. The cross-link observed was between Tpx2 (E-643) and the MT (K-336). 
The K-336 residue of  a-tubulin is localized on helix-10, which has been 
shown to be in the inter-dimer interface (Nogales et al., 1998). Similar 
conclusion was reached by Zhang et al., where they determined the cryo-EM 
structure of Tpx2 bound to the microtubule surface (Zhang et al., 2017). 
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Tpx2 interaction with the longitudinal and lateral tubulin interface occurs 
through two flexible regions termed “ridge” and “wedge”. The wedge region 
consists of the short helix-10 and binds in-between adjacent protofilaments. 
This mode of interaction with the MT suggests that Tpx2 stabilizes the 
microtubules through promoting interaction between the tubulin subunits.  
 
 
Studies by Sturgill et al., suggest that Tpx2 does not play an explicit role in 
Kif15 targeting to the mitotic spindle (Sturgill et al., 2014). Rather, Tpx2-Kif15 
binding is an indirect consequence of the role of Tpx2 in MT bundling and k-
fibre formation. However, to support this idea, no interaction between Kif15 
and Tpx2 in the absence of microtubules would be detected. From our XL-MS 
data, we see that Tpx2 is able to bind Kif15 in the absence of microtubules, 
although this interaction has been reported to be of low affinity (Drechsler et 
al., 2014). Mutation experiments of these Kif15-Tpx2 interaction sites would 
be required to fully understand the role Tpx2 plays in Kif15 spindle targeting.  
 
6.1.4 Tpx2 adopts a dimeric conformation 
 
Tpx2 is an important regulator of microtubules, including MT nucleation (Petry 
et al., 2013). The C-terminal half of Xenopus Tpx2 has recently been 
characterised as consisting of distinct a-helical domains (a3-a7) (Alfaro-Aco 
et al., 2017). Despite these individual domains do not bind to the microtubules 
independently, but rather, the more of these individual domains are joined 
together, the higher their affinity to the microtubules. This would suggest that 
Tpx2 dimerization enhances its microtubule binding affinity. However, 
Roostalu et al., report that Tpx2 purified under high-ionic strength conditions 
(300 mM KCl), exists as a monomer (Roostalu et al., 2015). From our own 
data, we see that under physiological strength (75 mM), Tpx2 exists as a 
dimer. This may be another case whereby protein oligomerisation is regulated 
through ionic interactions. It would be interesting to test whether the 
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oligomerisation state of Tpx2 enhances the affinity of the protein to bind the 
microtubules. 
 
 
6.1.5 Kif15 Knock-out CRISPR cell lines  
 
As presented in chapter 5, we have been able to obtain two types of Kif15 
RPE1-mCherry-tubulin CRISPR clones with distinct phenotypes. The CRISPR 
gRNA used targets exon 1 of Kif15 and the clones were screened using 
immunofluorescence. One clone is depleted of Kif15, whereas the second 
Kif15 clone is depleted from the spindle, but exclusively localises to the 
kinetochores. Further work, including sequencing of the clones will need to be 
carried out to identify the INDELS in the genome sequences. Sturgill et al., 
have also generated a Kif15 HeLa cell line largely lacking Kif15 using the 
CRISPR-Cas9 system (Sturgill et al., 2016). However, they used a sgRNA 
targeting exon 20 of Kif15, suggesting some endogenous Kif15 (up to amino 
acid ~800) is still present in the cells. The Kif15 knock-out cell line generated 
can be used to provide a greater understanding of the role Kif15 plays in 
bipolar spindle assembly; mutations in Kif15 can be tested in these cells 
lacking endogenous Kif15 to study the effect of Kif15 tetramerization, Tpx2 
binding and phosphorylation on Kif15 function and localisation.  
 
It is known that the N-terminal residues of kinesins are required for force 
generation, thus any construct lacking these amino acids, such as the one 
used by Reineman et al., may affect the mechanochemical properties of a 
motor (Khalil et al., 2008). Our preliminary CRISPR data where the cut site is 
localized to the N-terminal residues of the Kif15 motor has also shown an 
interesting phenotype in clone MC174, where the motor is localized to the 
microtubule plus-end or the kinetochore. Preliminary work on Kif15 has 
shown that the motor does not co-localise with the kinetochores (Vanneste et 
al., 2009), however more recent work has shown Kif15 to co-localise with 
Hec-1 at the kinetochores (Sturgill and Ohi, 2013). From our data, it is not 
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clear whether Kif15 is accumulated on the plus-ends as seen in in-vitro 
reconstitution experiments (Drechsler and McAinsh, 2016) or localised on 
the kinetochores. However, given that the Cas9 enzyme cuts between the 5th 
and 6th nucleotide of Kif15 exon 1, this could generate a hyperactive 
mutation in the cover strand of the motor, which shows Kif15 motors at the 
microtubule plus-ends or the kinetochores. This is consistent with data from 
Kinesin-1, whereby mutations in the N-terminal cover-strand residues 
promoted increased processivity of the motor (Khalil et al., 2008). 
 
 
6.1.6 XL-MS of Kif1C 
 
  
Our optimised XL-MS method and analysis workflow has also been adopted 
to study the organisation of Kinesin-3 Kif1C, in collaboration with N. Siddiqui, 
Straube lab. This data revealed that Kif1C adopts an auto-inhibited 
conformation, whereby two of the back-folding cross-links identified makes 
contact with the same lysine residue in the motor domain. This lysine residue 
has been shown to make contacts with the microtubule surface, thus it is likely 
that autoinhibition using the tail prevents motor head binding to the 
microtubules. This is another example of how XL-MS was used to study 
structural organisation of Kinesin.  
 
 
6.2 Conclusion and future directions  
 
In conclusion, work presented in this thesis has progressed our understanding 
of the Kif15 molecular motor at a structural level. We confirmed that Kif15 is 
indeed a tetramer, which most likely adopts a parallel dimer-of-dimers 
conformation. We also revealed how Tpx2 inhibits Kif15 through the 
stabilisation of its autoinhibited conformation. There are several key 
experiments which would further advance our understanding of how Kif15 is 
regulated. Firstly, confirming the parallel tetramer organisation of Kif15 by 
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optimising EM experiments is essential and potentially using cryo-EM to 
provide high resolution structural information. Also, in-vitro Aurora A 
phosphorylation assays of Kif15, followed by XL-MS, would aid the 
understanding of what conformational effects this kinase phosphorylation has 
on the structure of Kif15 and its interaction with Tpx2. Single-molecule assays 
could also be used to study the effects of Aurora A phosphorylation on Kif15 
motility. Point mutations of the tetrameric cross-links and interaction sites for 
Tpx2 should be explored in-vivo using the generated CRISPR Kif15 knock-out 
cell lines, to study what effect they have on Kif15 localisation and function. 
Also, further understanding of Kif15 function in cells can be achieved; with 
Cas9 cutting at N-terminus we can now make GFP knock-in cell lines and 
purify endogenous motor complexes to look for binding partners, do the in-
vivo cross-linking on beads and investigate post-translational modifications of 
this motor. More broadly, these tools should also enable the non-mitotic 
functions of Kif15 to be investigated. 
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